
==== Front
Discov Nano
Discov Nano
Discover Nano
2731-9229
Springer US New York

39251461
4100
10.1186/s11671-024-04100-x
Review
Therapeutic effect of targeted antioxidant natural products
Mukherjee Sohini 1
Chopra Hitesh 27
Goyal Rajat 3
Jin Sihao 4
Dong Zhenzhen 4
Das Tanmoy 5
Bhattacharya Tanima btanima1987@gmail.com

6
1 https://ror.org/01e7v7w47 grid.59056.3f 0000 0001 0664 9773 Department of Environmental Science, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, West Bengal 700019 India
2 grid.412431.1 0000 0004 0444 045X Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu 602105 India
3 https://ror.org/02k949197 grid.449504.8 0000 0004 1766 2457 MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana 133207 India
4 https://ror.org/05p2fxt77 grid.469542.8 Department of Nursing, School of Medicine, Shaoxing Vocational and Technical College, Shaoxing, 312000 China
5 https://ror.org/02yd50j87 grid.512179.9 0000 0004 1781 393X Faculty of Engineering, Lincoln University College, 47301 Petaling Jaya, Selangor Darul Ehsan Malaysia
6 https://ror.org/02yd50j87 grid.512179.9 0000 0004 1781 393X Faculty of Applied Science, Lincoln University College, 47301 Petaling Jaya, Selangor Darul Ehsan Malaysia
7 https://ror.org/057d6z539 grid.428245.d 0000 0004 1765 3753 Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401 India
10 9 2024
10 9 2024
12 2024
19 1 14424 5 2024
28 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The exploration of targeted therapy has proven to be a highly promising avenue in the realm of drug development research. The human body generates a substantial amount of free radicals during metabolic processes, and if not promptly eliminated, these free radicals can lead to oxidative stress, disrupting homeostasis and potentially contributing to chronic diseases and cancers. Before the development of contemporary medicine with synthetic pharmaceuticals and antioxidants, there was a long-standing practice of employing raw, natural ingredients to cure a variety of illnesses. This practice persisted even after the active antioxidant molecules were known. The ability of natural antioxidants to neutralise excess free radicals in the human body and so prevent and cure a wide range of illnesses. The term "natural antioxidant" refers to compounds derived from plants or other living organisms that have the ability to control the production of free radicals, scavenge them, stop free radical-mediated chain reactions, and prevent lipid peroxidation. These compounds have a strong potential to inhibit oxidative stress. Phytochemicals (antioxidants) derived from plants, such as polyphenols, carotenoids, vitamins, and others, are central to the discussion of natural antioxidants. Not only may these chemicals increase endogenous antioxidant defenses, affect communication cascades, and control gene expression, but they have also shown strong free radical scavenging properties. This study comprehensively summarizes the primary classes of natural antioxidants found in different plant and animal source that contribute to the prevention and treatment of diseases. Additionally, it outlines the research progress and outlines future development prospects. These discoveries not only establish a theoretical groundwork for pharmacological development but also present inventive ideas for addressing challenges in medical treatment.

Keywords

Targeted therapy
Natural products
Antioxidants
Oxidative stress
Therapeutics
issue-copyright-statement© Springer Science+Business Media, LLC, part of Springer Nature 2024
==== Body
pmcIntroduction to targeted antioxidant natural products

Antioxidants are compounds that impede or suppress free radical reactions, thereby retarding or preventing cellular damage. While the specifics of antioxidant defenses vary among different species, the universal presence of antioxidant defenses is noteworthy. These defenses manifest in both enzymatic and non-enzymatic forms, existing in both the intracellular and extracellular environments. Natural antioxidants, derived from plants and other living organisms, possess significant potential to counteract oxidative stress. They achieve this by regulating the formation of free radicals and scavenging them. Additionally, they disrupt the chain reactions initiated by free radicals and prevent the lipid peroxidation [1].Consequently, these natural antioxidants have the ability to restore cellular homeostasis, effectively balancing irregular oxidative stress. As a result, they can mitigate the harmful effects of various oxidative stress-induced pathological conditions [2].The historical use of crude natural plant products to address diverse diseases has been a longstanding practice for thousands of years. This tradition predates the advent of modern medicine and synthetic drugs, regardless of whether the active antioxidant molecules were understood [3].

The World Health Organization (WHO) has reported that 80% of the global population relies on traditional medicine for their primary healthcare needs [4]. A significant portion of these treatments involves the use of herbal extracts and their active components. Numerous bioactive extracts from medicinal plants, along with their identified or isolated active constituents, exhibit diverse pharmacological properties against both acute and chronic diseases and disorders [5–7].

Presently, the impact of oxidative stress and its related factors has emerged as a crucial concern for human health. In situations of heightened stress, the production of reactive oxygen species (ROS), such as hydroxyl radicals, superoxide anion radicals, and hydrogen peroxide, intensifies. The body's endogenous enzymatic and nonenzymatic antioxidant substances may struggle to manage the excessive ROS load, resulting in imbalances in the process, cell damage, and subsequent health issues. Furthermore, the absence of antioxidant compounds further exacerbates these challenges [8, 9].Oxidative stress conditions induce changes in the cellular constituents of our body, contributing to various disease states. Effectively countering oxidative stress involves strengthening cellular defenses through the application of antioxidants [10, 11]. Certain compounds serve as in vivo antioxidants, enhancing the body's natural antioxidant defenses by upregulating the expression of genes responsible for enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSHPx), thereby increasing the levels of endogenous antioxidant [12, 13].

So far, research has focused on natural products with high antioxidant capacity, particularly those that people often (or could) eat. Oxygen Radical Absorbance Capacity (ORAC), 2,2-diphenyl-1-picrylhydrazyl (DPPH), scavenging method, ferric reducing capacity, and increasingly, the use of nanoprobes to evaluate antioxidants' metal-reducing capacity, are some of the in vitro chemical-based assays that have been developed for this purpose [14].

These tests use different approaches and provide different results on how reactive oxygen and nitrogen species (ROS/RNS) interact with the material. However, one in vitro chemical approach is not enough to thoroughly investigate the possible health-protective and antioxidant properties of natural compounds. It is essential to assess and compare antioxidant capabilities using various approaches due to the complexity of their in vivo processes. The chemical tests also don't take into account bioavailability and lipophilicity, two important factors in biological settings. Hence, it's possible that the derived antioxidant capacity indices don't accurately represent the antioxidant effects that a specific sample would have in a living organism. It is also necessary to assess whether or not natural compounds may stimulate a cellular antioxidant response. Being an effective radical scavenger and reducing agent is just part of what makes an antioxidant effective. However, it is a chemical that may alleviate oxidative stress by activating transcription factors, which in turn increase the development of antioxidant enzymes. Some degenerative illnesses, including as cancer, heart disease, Alzheimer's disease, neurological disease, and inflammatory disorders, may begin earlier in life in those whose diets are lacking in antioxidant-rich foods. [15–21]. Addressing human health concerns can be achieved by incorporating antioxidant compounds from natural plant sources into daily dietary practices. These natural sources of antioxidants have the potential to serve as preventive medicine. Recent research indicates a correlation between the consumption of antioxidant-rich foods in the diet and a lower prevalence of human illnesses [22].

Therapeutic applications of targeted antioxidant natural products

Cardiovascular diseases and antioxidant natural products

Resveratrol

Research on the possible function of Resveratrol, a polyphenolic molecule present in grapes and red wine, in Cardio Vascular Diseases (CVDs) has been conducted [23]. Vascular health depends on an increase in the availability of nitric oxide, and resveratrol seems to have antioxidant and anti-inflammatory effects, as well as the potential to upregulate endothelial NO synthase [24]. Resveratrol targets molecular pathways including SIRT-1, AMPK, Nrf2, and NFκB, which may help disorders such as atherosclerosis, hypertension, stroke, myocardial infarction, and heart failure, according to studies (as shown in Fig. 1) [25–29]. To validate resveratrol's effects in CVDs, more human clinical trials are required, despite encouraging results from preclinical investigations. Researchers have also looked at how resveratrol affects left ventricular function and heart failure (HF), finding that it may help diabetic individuals' hearts work better [30]. The chemical promotes autophagy and interacts with several molecular targets associated with cardiovascular disorders; this may help prevent pathological remodeling of the heart by lowering inflammation and oxidative stress. Supplemental resveratrol may reduce blood pressure by stimulating the body to produce more nitric oxide, which in turn relaxes blood vessels, according to research [31]. The antioxidant and nitric oxide-enhancing effects of resveratrol are mostly responsible for the lowering of blood pressure. Clinical research has shown that resveratrol, when taken in addition to traditional antihypertensive medication, effectively lowers blood pressure levels [32]. Furthermore, resveratrol may have preventive effects on the liver since it has been linked to lower plasma concentrations of certain enzymes involved in liver damage [33]. Keep in mind that resveratrol's effect on blood pressure could differ from person to person depending on things like dose and genetics. Research suggests that there may be a positive impact on blood pressure when using greater doses of resveratrol, particularly in diabetic individuals, when taken daily in quantities of 300 mg or more [34]. Overall, resveratrol's antioxidant and vasodilatory actions show promise in lowering blood pressure, but further study is required to determine an appropriate dose and determine how it affects various groups. Results from resveratrol-related clinical studies have shed light on the supplement's possible advantages for the treatment of heart conditions. Patients undergoing cardiovascular surgery were the subjects of the "Short Interval Resveratrol Trial in Cardiovascular Surgery (SIRT-CVS)" research (NCT03762096), which sought to determine the efficacy and safety of short-interval resveratrol therapy [35]. The potential benefits of resveratrol on cardiovascular health and arterial function in the elderly were the subject of NCT02909699 [36]. These studies help fill gaps in our knowledge of how resveratrol affects heart health. Resveratrol has been shown in both animal studies and human trials to have beneficial effects on cardiac function, including improving diastolic and systolic performance, decreasing remodeling of the atrium and left ventricle, and influencing a number of signal transduction pathways associated with cardiovascular disorders [37].Fig. 1 Therapeutic cardio protective actions of Resveratrol

Vitamin C

An abundance of naturally occurring foods include vitamin C. Vitamin C is abundant in guavas, and the lemon. Cruciferous vegetables, such as broccoli, provide an additional source of vitamin C, alongside citrus fruits. Vitamin C's potential role in preventing and treating CVDs has piqued researchers' interests. Although scurvy due to a traditional vitamin C deficit is rather uncommon, studies have linked plasma vitamin C concentrations—even those that are considered normal—to various risks of cardiovascular disease. In addition to the recommended daily allowance, some research suggests that larger dosages of vitamin C may have positive effects on cardiovascular health. One of the main factors in the development of CVD is the oxidation of LDL-protein, which vitamin C's antioxidant qualities play a critical role in blocking [38–41]. Nevertheless, there is inconsistent evidence from both cohort studies and randomized trials about the association between vitamin C consumption and the risk of cardiovascular disease, therefore the existing research does not provide strong support for the widespread use of vitamin C supplements to lower CVD risk. Curiously, there have been studies that have shown an increased risk of cardiovascular disease while using vitamin C supplements. This begs the issues of how supplementation differs from dietary vitamin C and what amounts are best to reduce the risk of heart disease.

The potential of vitamin C as a therapeutic agent for heart conditions has been investigated in clinical studies. In one trial, NCT02762331, the researchers looked at how patients undergoing heart surgery responded to low levels of inflammation after taking large doses of ascorbic acid (vitamin C) [42]. The purpose of another study, NCT03123107, was to learn more about the effects of ascorbic acid on people having coronary artery bypass graft surgery so that we might improve our understanding of vitamin C's role in cardiovascular health [43]. Another research that looked at reducing organ failure after a cardiac arrest by using high-dose intravenous vitamin C was published [44]. Organ failure, neurological sequelae, mortality, and other parameters were examined in this double-blind, multi-center experiment that examined the effects of additional or very high-dose intravenous vitamin C in patients with cardiac arrest and restoration of spontaneous circulation. The involvement of vitamin C in reducing inflammation, advancing cardiovascular research, and post-cardiac arrest care is highlighted by these clinical studies, which provide vital insights into its prospective advantages and impacts in cardiac therapy.

Vitamin E

There is plenty of vitamin E-rich foods that are easy to integrate into a balanced diet. Wheat germ oil is abundant and one of the best sources. In addition to wheat germ oil, this vital component may be found naturally in nuts and seeds. Half an avocado contains as much as 20% of the recommended daily allowance of vitamin E, making them a multipurpose fruit that is also rich in this vitamin. Red bell peppers, salmon, trout, pine nuts, peanuts, peanut butter, and peanuts are among the many foods that are high in vitamin E. Concerning CVDs, vitamin E has garnered attention, especially for its potential effects on heart health. There is some evidence that vitamin E may help reduce the risk of cardiovascular diseases, including atherosclerosis and coronary heart disease. Vitamin E-rich foods may reduce the incidence of coronary heart disease in middle-aged and older people, according to studies. To avoid cardiovascular disease, the American Heart Association recommends eating meals rich in antioxidant vitamins and other nutrients rather than taking vitamin E pills. Vitamin E may raise the risk of overall mortality, heart failure, and hemorrhagic stroke, according to some research, and clinical trials have failed to reliably show that it helps prevent CVDs. Even while vitamin E has shown cardio protective effects in some patient subgroups exposed to high levels of oxidative stress, it is unclear if indiscriminate use of the vitamin will have any positive impact on cardiovascular health in populations that are not carefully screened [45–47]. Important insights into vitamin E's benefits have been gleaned from clinical studies that have focused on heart disorders. Supplemental vitamin E did not reduce the incidence of coronary heart disease in high-risk individuals, according to one research published [48]. Another group of researchers also highlighted a research that found no substantial impact of vitamin E supplementation on the incidence of cardiovascular disease or cancer in randomized trials [49]. Furthermore, studies documented have linked vitamin E-rich foods to a reduced risk of coronary heart disease in middle-aged and older adults, highlighting the significance of these foods as dietary sources of vitamin E [50].

Randomized controlled trials and observational studies have investigated beta-carotene's effects on heart disorders. Some observational studies have uncovered evidence of a preventive effect of beta-carotene against coronary heart disease. On the other hand, outcomes from RCTs have been inconsistent. Supplementing with beta-carotene did not reduce the risk of cardiovascular disease and instead raised the risk of death from cardiovascular causes, according to a meta-analysis and systematic review of randomized controlled trials [51–53]. Results from subgroup studies revealed an increased risk of cardiovascular events associated with low-dose, individual beta-carotene therapy.

Polyphenols

Beyond their antioxidant powers, polyphenols have a multitude of positive impacts on heart health [54]. Important in reducing the chronic inflammation linked to CVD, they also have anti-inflammatory characteristics. Polyphenols aid in cardiovascular disease prevention by lowering inflammatory processes, an important factor in atherosclerosis and other inflammatory disorders [55–57]. The endothelium is responsible for regulating blood pressure and clotting; polyphenols impact heart health via increasing endothelial function. They lessen the likelihood of cardiovascular illness by increasing the generation of nitric oxide (NO), a chemical necessary for vasodilation (the widening of blood vessels). This process increases blood flow and lowers blood pressure [58–61]. A diet abundant in plant-based foods, such as fruits, vegetables, whole grains, and polyphenols, is important for heart health for many reasons. These foods are an important part of a heart-healthy lifestyle because of the polyphenols they contain, which may help prevent and manage cardiovascular disease. However, eating foods that are high in polyphenols is good, but it shouldn't be the only thing people do to keep their hearts healthy [62]. Polyphenols have the potential to influence gene expression, enzyme activity, and intracellular signaling pathways that are associated with cardiovascular health, according to research. Polyphenols prevent cardiovascular disease by controlling these pathways, which in turn protects the heart from inflammation and oxidative stress. Better lipid profiles, mitochondrial function, and cellular metabolism are all hallmarks of a heart-healthy lifestyle, and polyphenols have been associated to these benefits.

Research has shown that polyphenols have several beneficial benefits on the cardiovascular system, such as reducing inflammation, protecting against blood clots, and lowering blood pressure [63]. Polyphenols are useful in the treatment and prevention of cardiovascular disorders due to their characteristics. By using the antioxidant potential of polyphenol-rich foods like tea, coffee, chocolate, olive oil, and red wine, a heart-healthy diet may be achieved.

Flavanoids

By acting as an antioxidant, flavonoids greatly mitigate oxidative stress in the cardiovascular system. Because of their capacity to fight oxidative stress and inflammation in the cardiovascular system, these chemicals—which are prevalent in many plant-based foods—have been associated with cardioprotective potential. It has been shown that flavonoids, such as anthocyanins, may slow the development of arteriosclerosis by reducing oxidative stress in heart cells [64]. Research has shown that flavonoids have a preventive role in cardiovascular health due to their ability to control oxidative stress-related processes, affect intracellular signaling pathways, and counter inflammation. Important components in preserving cardiovascular health and lowering the risk of cardiovascular illnesses include flavonoids' association with enhanced flow-mediated dilation, decreased blood pressure, and prevention of LDL oxidation [65–67]. To promote heart health and prevent cardiovascular disorders, flavonoids are useful components due to their antioxidant characteristics, which include scavenging free radicals and inhibiting enzymes involved in oxidative stress [68].

Cyanidin 3-O-glucoside and delphidin 3-O-glucoside are two examples of the anthocyanin flavonoids that have been shown to slow the development of atherosclerosis by reducing oxidative stress in heart cells [69, 70]. According to research, flavonoids have many anti-oxidant and anti-free radical functions, including scavenging free radicals, inhibiting oxidative stress enzymes, and reducing ROS produced during mitochondrial respiration [65, 66, 71]. Flavonoids help maintain a stable and less reactive radical environment in the cardiovascular system by efficiently inactivating free radicals via their highly reactive hydroxyl groups [64]. Flavonoids are known to promote cardiovascular health by increasing antioxidant activities and decreasing LDL oxidation and platelet aggregation [65]. Flavonoids have a crucial role in preserving heart health and warding off cardiovascular illnesses because, when supplemented with other antioxidants, they form a strong defense mechanism against oxidative stress in the cardiovascular system.

Scientific studies support the idea that flavonoid consumption in the diet might help reduce the risk of cardiovascular illnesses and other systemic health problems [72–76]. It is worth noting that flavonoids may have cardioprotective properties, since epidemiologic studies have linked flavonoid consumption to a reduced risk of cardiovascular illnesses [77]. The research emphasized the significance of flavonoids in promoting heart health and lowering risk of cardiovascular disease. Another subgroup of flavonoids, flavonols have recently attracted attention for their potential effects on cardiovascular risk [78]. Research has shown that flavonols have antioxidant, anti-atherogenic, antithrombotic, and vasodilatory effects, which in turn serve to protect against cardiovascular disorders [78–82].

Omega fatty acids

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids that have been shown in clinical trials and studies to considerably lower the risk of sudden death due to cardiac arrhythmias and all-cause mortality in individuals with established coronary heart disease [83]. These fatty acids have several uses in the management of cardiovascular diseases, including the treatment of hyperlipidemia and hypertension. Omega-3 fatty acid-rich fish is recommended for heart health by the American Heart Association, regardless of a person's history of coronary heart disease [84]. Research has shown that omega-3 fatty acids may help lower cardiovascular risk factors including those that contribute to blood clotting and excessive levels of low-density lipoprotein cholesterol [85, 86]. In addition, omega-3 fatty acids have been linked to better lipid profiles, lower blood pressure, and protection against cardiovascular disorders such as heart attacks and strokes, particularly in those who already have them [84, 87].

Lycopene

Lycopene, a carotenoid included in red fruits and vegetables (especially tomatoes), is important for heart health because it reduces the effects of oxidative stress. In oxidative stress, the body's capacity to neutralize ROS or restore damaged cells is inadequate relative to the amount of ROS produce. The positive benefits of lycopene during the earliest stages of atherosclerosis were shown in rabbits, who exhibited improvements in the LDL/HDL ratio, HDL functioning, and decreased cholesterol buildup in the aorta, even though lycopene cannot raise HDL cholesterol (as shown in Fig. 2) [88]. Research has demonstrated that lycopene has various cardio-protective effects, including reducing oxidative stress caused by ROS production [89], preventing oxidative damage caused by LDL [90], enhancing endothelial functions [88], and promoting ventricular remodeling by preventing apoptosis [91]. By inhibiting endothelial injuries, preventing cholesterol by prohibiting 3-hydroxy-3-methylglutaryl coenzyme, and reducing prophylaxis progression, thrombotic progression, and atherosclerosis complications, lycopene's potential antioxidant properties were able to accomplish this. The enzyme a reductase influences molecular pathways that regulate cell division and apoptosis; it also promotes efflux of cholesterol, inhibits the pro-inflammatory activity of T lymphocytes and macrophages, and inhibits the production of foam cells and smooth cells [92].Fig. 2 Cardio-protective action of Lycopene

By influencing HDL function towards an anti-atherosclerotic phenotype—characterized by decreased serum amyloid A levels and beneficial alterations in HDL remodeling enzymes (cholesterol ester transfer protein and lecithin cholesterol acyltransferase)—lycopene reduces the production of dysfunctional HDL [93]. Only those with high blood triglyceride levels to begin with saw a hypo-triglyceridemic response from tomato juice [94].Results from clinical research looking into lycopene's benefits on heart health are encouraging. A randomized controlled experiment looked at how taking lycopene supplements orally affected vascular function in both healthy volunteers and those with cardiovascular disease. The results showed that it may help improve endothelial function and decrease arterial stiffness [95, 96]. Results from these studies show that lycopene may be useful in the management of a variety of cardiovascular diseases due to its antioxidant, anti-inflammatory, antihypertensive, antiplatelet, anti-apoptotic, and protective endothelial properties. Further well-designed studies are necessary to clarify the beneficial benefits of lycopene on cardiovascular health and to investigate its potential as a supplement or dietary component for the prevention and treatment of cardiovascular illnesses, especially since there have been reports of inconsistent findings [97]. Exploring the synergistic effects of lycopene with other dietary components and creating functional meals to help prevent and cure cardiovascular illnesses are potential areas for future study [98, 99].

Neurological diseases and antioxidant natural products

Neurodegenerative disorders have complex etiologies and progressions due to several pro-neurodegenerative variables. These diseases are characterized by neuronal cell death, inflammation, protein and DNA damage, mitochondrial malfunction, and amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Important risk factors for neurodegeneration include age, high blood pressure, type II diabetes, obesity, insulin resistance, depression, and brain trauma, in addition to this primary driver [100, 101]. There are a number of lifestyle variables that contribute to the development, progression, and overall impact of these crippling diseases. These include eating a lot of sugar or fat, as well as being addicted to alcohol or tobacco. The involvement of neuroinflammation and excessive inflammatory responses, which can worsen neurodegenerative processes, is fundamental to all of this. There is hope that the terrible impacts of neurodegenerative disorders can be slowed or prevented by addressing these several pro-neurodegenerative variables with a mix of antioxidant treatments, lifestyle changes, and anti-inflammatory measures [5, 7, 102].

Lycopene

A variety of neurological problems have been studied for their possible neuroprotective benefits, and lycopene—a carotenoid found in red fruits and vegetables—has been one of them. Because it is lipophilic, it may pass the blood–brain barrier and enter the CNS directly, where it can have an impact [100]. One of the main reasons why lycopene can protect neurons is because of its powerful antioxidant capabilities. These properties help to reduce inflammation and oxidative stress, which are key players in the development of neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's. Neurodegenerative diseases, epilepsy, cognitive loss with age, subarachnoid hemorrhage, spinal cord injury, neuropathy, and other neurological illnesses may all benefit from lycopene's therapeutic properties [101–103]. Evidence suggests it may reverse the pathophysiological and behavioral alterations brought on by these diseases. There are a number of neuropathological effects associated with a high-lipid diet, and lycopene may help reduce their effects [104].

Curcumin

Researchers have looked at the neuroprotective benefits of curcumin, a chemical extracted from turmeric, in a number of neurological diseases. It has a number of documented effects, including regulating neurotransmitter levels, improving neurogenesis in the adult hippocampus [105, 106], and blocking the development of reactive astrocytes [107, 108], which may protect cells from death. Animal studies on diabetic neuropathy, dyskinesia, and serious depression have shown that curcumin provides protection [109–113]. Its anti-inflammatory and antioxidant capabilities are believed to be the primary mechanisms by which it protects neurons. Seizures, migraines, ALS, PD, MS, and neuroinflammation are some of the other conditions that curcumin has shown good results in animal models [114–117]. Its low oral bioavailability, however, restricts its application in therapeutic contexts [118].

Research on the possible therapeutic benefits of curcumin, a turmeric component, in Alzheimer's disease (AD) has been ongoing. Research in aged Tg2576 mice with advanced amyloid buildup has shown that it hinders the development of Aβ40 and Aβ42 oligomers, lowers amyloid levels, and lessens plaque load [119]. In rats that were treated with Aβ, clinical research found that taking curcumin supplements greatly decreased the loss of synaptophysin [120].

Molecularly, curcumin's ability to affect several biochemical pathways and molecular processes is the bedrock of its therapeutic benefits on AD. It disrupts the process of amyloid-beta (Aβ) peptide aggregation in the AD brain by weakening Aβ fibrils, which play a crucial role in the development of amyloid plaques [121, 122]. The aggregation of Aβ is essential to be disrupted since these plaques are directly associated with the neurodegeneration seen in AD. By influencing the AMP-activated protein kinase (AMPK) pathway, curcumin further mediates its neuroprotective properties [123–125]. By inhibiting AMPK pathway activation, curcumin improves neuronal lifespan by decreasing neuronal damage and apoptosis. Superoxide dismutase (SOD) and other antioxidant enzymes are made more active, and inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukins (IL-6 and IL-1β) are modulated as part of this process [125].

In addition, curcumin may change gene expression that contributes to the advancement of AD without modifying the DNA sequence, due to its epigenetic actions [126, 127]. Genes linked in neuroprotection and cognitive function are upregulated, whereas genes implicated in inflammation are downregulated. Curcumin is known to modulate the activity of transcription factors and signaling molecules that are implicated in neuroinflammation and neurodegeneration [128].

Polyphenols

In Alzheimer's disease patients, polyphenols show neuroprotective benefits via regulating pathways for Aβ synthesis, preventing Aβ aggregation, and decreasing macrophage Aβ absorption [129]. Inhibiting the production of α-synuclein misfolded aggregates, lowering mitochondrial dysfunction, altering cell survival and cell cycle genes, and modifying numerous signaling pathways implicated in PD are some of the neuroprotective characteristics of polyphenols, according to research [129, 130]. While adding to antioxidant activity, these chemicals may activate pathways such as phosphoinositide 3-kinase (PI3K)/Akt, mitogen-activated protein kinase (MAPK), and protein kinase C (PKC) [131–134]

Furthermore, in vitro models of PD-related disorders have shown that a particular combination of micronutrients and polyphenols may protect neurons from damage [135]. All things considered, polyphenols show potential as neuroprotective drugs in PD due to their ability to target many pathways that are involved in the illness.

Flavanoids

According to research, flavonoids may improve blood flow to the brain and prevent the accumulation of beta-amyloid plaque, two symptoms that are characteristic of AD [136]. The subclasses of flavonoids known to have possible positive effects on brain health and cognitive function include anthocyanins, flavanols, flavonols, and flavanones. The absence of precise mechanistic evidence, together with uncertainty about flavonoids' metabolism and bioavailability, has slowed their development as therapeutic approaches for AD. However there is evidence that diets high in flavonoids might affect cognitive decline and the disease [137].

Research has linked a reduced risk of PD to increased consumption of foods strong in anthocyanins, including berries [138]. This data points to the possibility that flavonoids, such as anthocyanins, lower the incidence of PD, especially in males. To fully grasp flavonoids' potential as therapeutic agents for PD, further study is required, since there are currently only a small number of clinical studies showing that they are effective in treating the disease.

Antioxidants in diabetes and obesity

Flavanoids

An important advantage of flavonoids is their capacity to decrease inflammation and oxidative stress, two elements that play a significant role in the onset and advancement of diabetes and obesity [139]. Flavonoids aid in maintaining the function of pancreatic β-cells, which are crucial for insulin generation, by removing free radicals and blocking pathways that promote inflammation. The anti-inflammatory and antioxidant properties of flavonoids make cells more sensitive to insulin, which in turn allows for better glucose absorption by cells and aids in the regulation of blood glucose levels [140].

In addition, enzymes like α-amylase and α-glucosidase, which are responsible for the breakdown of carbohydrates, may be inhibited by flavonoids, which allows them to directly impact glucose metabolism [141–143]. People with diabetes are able to avoid dangerously high blood sugar levels because to this enzymatic inhibition, which slows the release of glucose into the circulation after meals.

Flavonoids are involved in weight control and lipid metabolism in addition to their effects on glucose metabolism. They reduce levels of bad lipids like triglycerides and LDL cholesterol by controlling the activity of enzymes involved in lipid production and breakdown [144, 145]. In addition, certain flavonoids promote the breakdown of stored fats and inhibit the development of preadipocytes into adipocytes, therefore discouraging fat formation [146]. This helps fight obesity and lowers the risk of cardiovascular problems associated with obesity.

One possible way that flavonoids help with weight control is by regulating hunger and energy expenditure. These chemicals work by influencing the release of hormones that control hunger, which in turn makes people feel full on less food. Further assisting in the decrease of body fat, certain flavonoids have been shown to enhance energy expenditure by promoting thermogenesis in brown adipose tissue and improving mitochondrial activity [147, 148].

Insulin resistance, poor glucose metabolism, and excessive fat storage characterize the metabolic diseases diabetes and obesity, which are interrelated and may be effectively managed and prevented with the help of vitamins [149]. These vital nutrients play an important role in metabolic health; while the body only needs a little quantity of them for many physiological processes, they impact the pathophysiology of diabetes and obesity via several pathways.

Vitamins

Vitamins D, E, and the B-vitamins have shown very encouraging results when used to the setting of diabetes. For example, vitamin D affects insulin secretion and sensitivity in addition to its well-known functions in calcium metabolism and bone health [150, 151]. Researchers have shown that people with enough vitamin D in their bodies are less likely to develop type 2 diabetes [152]. This may be because vitamin D improves insulin sensitivity and pancreatic β-cell activity. Antioxidant vitamin E shields cells from oxidative damage, which is common in diabetics because of their high blood sugar levels [153]. Vitamin E aids in the prevention or delay of diabetic consequences such cardiovascular illnesses and neuropathy by lowering oxidative stress. Since elevated homocysteine levels are linked to an increased risk of cardiovascular disease in diabetic individuals, they could potentially contribute to lowering the risk of diabetes by altering these levels.

Vitamins have an impact on energy metabolism, hunger, fat synthesis/storage, and overall body weight/fat distribution in relation to obesity. For instance, low vitamin D levels are related with more body fat and an increased risk of becoming obese; this vitamin is also involved with the management of body weight [154]. Vitamin D may provide an explanation for this correlation if it has a function in the metabolism of fat cells and may affect the expression of genes related to energy expenditure and fat accumulation. In addition, vitamin E and C's antioxidant qualities might lessen the oxidative stress that comes with obesity, which aids in lowering inflammation—a major contributor to the onset of obesity-related problems [155–157].

Polyphenols

Polyphenols have the potential to significantly impact glucose metabolism and insulin sensitivity, two key components in the management of diabetes as shown in Fig. 3 [158]. One of the main causes of insulin resistance, malfunction of β-cells, and the advancement of diabetes is oxidative stress. Polyphenols contribute in the maintenance of normal blood glucose levels by protecting pancreatic cells and improving their insulin production by neutralizing ROS [159–161]. Additionally, many polyphenols have the ability to block enzymes such as α-glucosidase and α-amylase, which play a role in the digestion of carbohydrates [162, 163]. This results in a reduced rate of glucose release into the circulation and the prevention of increases in glucose levels after a meal.Fig. 3 Antidiabetic effects of dietary polyphenols

In addition to their antioxidant and anti-inflammatory effects, polyphenols help alleviate the chronic inflammation that accompanies obesity and insulin resistance [164–166]. Evidence suggests that polyphenols have many modes of action that affect obesity-related weight control and body composition. As a result of their ability to control lipid metabolism, they may lessen the buildup of fat in the body by increasing lipolysis and decreasing lipogenesis [167]. A negative energy balance and weight reduction may be aided by some polyphenols, which have the ability to enhance energy expenditure and fat burning. Their impact on the gut microbiota has also recently come to light, as changes in the make-up and function of gut bacteria have been associated with changes in metabolic health and obesity. In a nutshell, polyphenols may aid weight loss by encouraging the development of good bacteria in the digestive tract [168–170].

Curcumin

Curcumin is involved with diabetes in many different ways. Oxidative stress, caused by an overabundance of ROS, is prevalent in diabetes patients and may be alleviated by its potent antioxidant capabilities. Curcumin may aid in protecting pancreatic cells and enhancing insulin sensitivity by reducing ROS and increasing the body's natural antioxidant defenses [171, 172]. Further assisting in the increase of insulin sensitivity and the avoidance of diabetic complications, curcumin's anti-inflammatory properties are crucial in treating the chronic inflammation associated with diabetes.

It has been shown that curcumin modulates many pathways associated with glucose metabolism, in addition to its antioxidant and anti-inflammatory functions. It has the potential to improve lipid metabolism, decrease gluconeogenesis in the liver, and increase glucose absorption in peripheral organs. Glycemic control and the likelihood of hyperglycemia are both improved by these measures [173–175]. Furthermore, research has shown that curcumin may hinder the action of digestive enzymes like α-glucosidase and α-amylase. This results in a reduced rate of glucose release into the circulation after carbohydrate-rich meals, and thus, it can avoid rises in blood glucose levels after eating.

As an effective drug in the prevention and management of obesity, Curcumin regulates lipid metabolism by boosting lipolysis and decreasing adipogenesis [176–178]. Researchers have shown that curcumin may prevent fat storage by reducing the expression of many adipogenic genes and transcription factors. The low-grade inflammation in adipose tissue, a common symptom of obesity and metabolic syndrome, may be effectively addressed by its anti-inflammatory characteristics. In addition to its anti-obesity actions, curcumin may aid in the fight against weight gain and promotion of weight reduction by increasing thermogenesis and energy expenditure.

Curcumin has been demonstrated to modify important insulin signaling pathways at the molecular level. This includes increasing the expression of genes involved in glucose and lipid metabolism, such GLUT4, GLUT2, GLUT3, and PPAR-γ, and improving insulin-stimulated Akt phosphorylation [182, 183]. Curcumin downregulates genes related to de novo lipogenesis and enzymes involved in gluconeogenesis in the liver, which improves lipid balance and reduces glucose synthesis. Curcumin has the interesting capacity to change the makeup of the gut microbiota, which may explain why it improves insulin sensitivity [184]. Improving insulin sensitivity is one of the many benefits of curcumin, which works by influencing the microbiome of the intestines to improve barrier function and decrease inflammation.

Garlic

Garlic has several effects in the field of diabetes care. The fact that it has antioxidant qualities is important since oxidative stress is a key factor in the development of diabetes, which leads to insulin resistance and malfunction of pancreatic β-cells [179, 180]. Garlic may improve insulin sensitivity and secretion by reducing oxidative damage to cells and tissues by scavenging ROS. In addition, the anti-inflammatory properties of garlic may help reduce systemic inflammation caused by persistent hyperglycemia, which in turn regulates glucose metabolism [181, 182].

Direct anti-diabetic effects of garlic have also been shown. Animal models and people with diabetes have shown moderate drops in blood glucose levels after taking garlic supplements, according to some research [183, 184]. Theoretically, this impact is believed to be facilitated via many pathways, such as improving insulin sensitivity, boosting insulin secretion, and shielding pancreatic β-cells against cell death or malfunction. Furthermore, it has been noted that garlic may impact glucose metabolism via the inhibition of enzymes such as α-glucosidase and α-amylase, which play a role in carbohydrate digestion [185, 186].

Researchers believe that garlic's capacity to alter lipid metabolism and consequently decrease fat storage is a contributing factor to its anti-obesity benefits [187, 188]. Lipid profile improvements and lower total and LDL cholesterol levels have been linked to garlic supplementation [189]. Garlic also has the potential to increase energy expenditure and aid in weight reduction or maintenance by boosting thermogenesis and fat burning. Because chronic inflammation is a feature of adipose tissue in obese people and a cause of metabolic dysfunction, its anti-inflammatory characteristics are also pertinent in the context of obesity.

Role of antioxidants in cancer

Vitamins

Retinoids, which are a class of vitamin A derivatives, are essential for cell proliferation, differentiation, and death. Preventing cells from undergoing malignant changes relies on these activities. Some cancers, including skin, bladder, and lung cancers, may be less common in those who consume more vitamin A, according to epidemiological research [190, 191]. High dosages of vitamin A have the potential to be toxic, thus its therapeutic usage in cancer therapy must be carefully managed.

It is thought that vitamin C, a powerful antioxidant, shields cells from oxidative DNA damage, which may cause cancer. It improves the body's antioxidant defence system as a whole and aids in the regeneration of other antioxidants. Although its effectiveness as a direct anticancer agent is still up for debate, high-dose vitamin C has been investigated as a potential supplementary treatment for cancer [192–194]. Some studies have shown that it helps mitigate the adverse effects of radiation and chemotherapy [195–197]. The anticancer effects of vitamin D are associated with its function in controlling cell proliferation, differentiation, and death [198]. Research including observational studies has linked increased vitamin D levels to a decreased likelihood of developing colorectal, breast, and prostate cancers [199–202]. As a possible adjuvant cancer therapy or cancer preventative, vitamin D's ability to slow cancer cell development and decrease metastasis is noteworthy. Vitamin E is another potent antioxidant that has been studied for its potential to lower cancer risk by defending against oxidative stress and inflammation, which are two important variables in the development of cancer [203]. There is conflicting data on vitamin E's preventive impact against many cancers, and excessive dosages may cause side effects; yet, some studies have shown that it may help prevent prostate and breast cancer [204, 205]. Damage to DNA and an increased risk of cancer have been associated with deficiencies of the B vitamins, which include folate (vitamin B9), vitamin B6, and vitamin B12 [206, 207]. These vitamins are crucial for DNA synthesis and repair. One possible explanation for the link between folate and a lower risk of cancers of the colon, breast, and cervical regions is the function it plays in DNA methylation, an essential step in controlling gene expression [208].

Polyphenols

One important component of polyphenols' anticancer effects is their antioxidant activity. Polyphenols aid in preventing DNA and other cellular components from oxidative damage—which may cause mutations and cancer—by scavenging ROS and increasing the body's natural antioxidant defense mechanisms [209, 210]. Chronic inflammation is known to increase the risk of cancer, although polyphenols' anti-inflammatory characteristics may help alleviate this risk. Potentially reducing the risk of inflammation-driven carcinogenesis, polyphenols work by blocking pro-inflammatory pathways and cytokine synthesis [211, 212]. Polyphenols have direct effects on the development and proliferation of cancer cells [213, 214]. Their ability to regulate the cell cycle, induce programmed cell death (apoptosis), promote tumorangiogenesis (the creation of new blood vessels to nourish tumors), and control metastasis (the spread of cancer cells to other areas of the body) is well-established. On top of all that, polyphenols may also affect the hormonal balance of the body, which is important for malignancies like breast and prostate that rely on hormones for their growth [215]. Potentially lowering the incidence of hormone-related malignancies, certain polyphenols function as phytoestrogens by binding to oestrogen receptors and exerting modest estrogenic or anti-estrogenic actions [216].

Flavonoids are well-known not just for their antioxidant properties, but also for their ability to reduce inflammation. Many different kinds of cancer have chronic inflammation as a recognized risk factor. By decreasing inflammation and perhaps lowering cancer risk, flavonoids may block a number of enzymes and cytokines that are involved in the inflammatory process [217, 218]. Flavonoids modulate cell signallng pathways, which in turn impact the development and survival of cancer cells. They have the ability to stop cancer cells from multiplying, trigger programmed cell death, and stop new blood vessels from forming to feed tumors with oxygen and nutrients—a process known as angiogenesis. As an example, flavonoids have the ability to disrupt the PI3K/Akt and NF-κB pathways, which are used by cancer cells for growth and cell division [218, 219]. Without affecting healthy cells, flavonoids may inhibit tumordevelopment and induce cancer cell death by focusing on certain pathways. In addition, flavonoids may have a role as adjuvant drugs in cancer treatment since they increase the susceptibility of cancer cells to traditional radiation and chemotherapy. This might be accomplished by preventing the repair processes that cancer cells rely on to withstand the DNA damage caused by chemotherapy medications or by reducing the expression of drug efflux pumps, which cancer cells often overexpress in order to evade these therapies.

In particular, curcumin's strong anti-inflammatory effects play a significant role. A number of malignancies have chronic inflammation as a recognized risk factor for both their development and progression. Curcumin has the ability to reduce inflammation and may lower the risk of cancer formation by influencing the activity of several important molecules in the inflammatory pathway, including cyclooxygenase-2 (COX-2), nuclear factor-kappa B (NF-κB), and other cytokines [220–222]. Curcumin has the ability to fight cancer because of its antioxidant qualities. Curcumin protects cells from DNA damage that might cause malignant mutations by scavenging ROS and increasing the activity of the body's antioxidant enzymes [223, 224]. Preventing oxidative damage is essential for cellular integrity maintenance and avoiding cancer's early stages.

In addition, research has shown that curcumin has a direct impact on tumorcells, namely by reducing cell growth and triggering programmed cell death (apoptosis) in many cancer cell types. A number of signallng pathways, including as the Wnt/β-catenin, PI3K/Akt, and MAPK pathways, are disrupted by it, which in turn controls cell growth and survival as shown in Fig. 4 [222, 225, 226]. As a result of its action on these pathways, curcumin has the potential to reduce tumorsize and halt tumorprogression.Fig. 4 Image depicts the routes that tumors might take, starting with growth factors in cancer cells, and how curcumin can inhibit tumordevelopment by targeting certain signal transducing components. Once conjugated, curcumin binds to the infected area and suppresses the expression of pathways that induce tumors: PI3K, AKt, NP-κB, MAPK, and ROS

Angiogenesis is the process by which tumors create their own blood supply to maintain their development; curcumin may impede this process as well. Curcumin may deprive tumors of oxygen and nutrients by inhibiting the production of angiogenic factors including vascular endothelial growth factor (VEGF) [227]. Beyond its direct anticancer properties, curcumin may also improve the effectiveness of more traditional cancer therapies, such as radiation and chemotherapy. It may make cancer cells more sensitive to these therapies, which might lead to better patient outcomes with fewer side effects at lower dosages. As an additional piece of evidence for its potential use as a supplement to these treatments, curcumin may shield healthy cells from their deleterious effects [228].

Garlic

Allicin, diallyl sulphide, and S-allylcysteine are just a few of the bioactive chemicals found in garlic that have shown promise in preclinical cancer research, and this has piqued people's curiosity. Garlic inhibits cancer via a complex web of processes that includes regulating carcinogen metabolism, protecting antioxidants, boosting the immune system, preventing cancer cell multiplication, inducing apoptosis, and blocking angiogenesis [229].

One important mechanism by which garlic inhibits cancer is via influencing carcinogen metabolism. It lessens the possibility of carcinogens producing DNA damage that may lead to cancer by increasing the activity of enzymes that detoxify them [230, 231]. On top of that, the sulfur-containing chemicals in garlic may attach directly to carcinogens, making it easier to excrete them from the body and lowering their cancer-causing potential. One reason garlic may help prevent cancer is because of its antioxidant capabilities. These characteristics neutralize ROS, which are harmful to DNA and other parts of cells and can cause mutations and cancer. Garlic helps keep cells healthy and prevents cancer from starting by reducing oxidative stress [232, 233]. Garlic also enhances the immune system's capacity to fight cancer. By boosting the activity of immune cells including natural killer cells, macrophages, and lymphocytes, it improves the body's capacity to detect and eliminate cancer cells. Both cancer prevention and bolstering the body's natural defenses against tumor development rely on this immunomodulatory action [234, 235]. Inducing apoptosis, or programmed cell death, is an important technique for slowing the course of cancer, and chemicals found in garlic can do just that at the cellular level [236–239]. Research has shown that garlic may influence many molecular pathways related to cell cycle control and cell death, such as NF-κB activity inhibition and caspase enzyme activation, which in turn can reduce tumor development [240–243].

Clinical translation of antioxidants

The clinical translation of antioxidants for the treatment and prevention of human diseases presents several significant challenges. First and foremost, the complex nature of oxidative stress and antioxidant mechanisms in the human body poses a fundamental challenge. Oxidative stress results from an imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify these reactive intermediates or repair the resulting damage. Antioxidants can mitigate this imbalance by neutralizing ROS, but the effectiveness of this approach in a clinical setting is influenced by numerous factors, including the specific disease context, the timing of antioxidant administration, and individual patient differences [244].

Another major challenge lies in the bioavailability and pharmacokinetics of antioxidant compounds [245, 246]. Many antioxidants exhibit poor solubility, stability, and absorption when administered orally, which can significantly limit their therapeutic potential. Efforts to improve these properties through formulation strategies or chemical modification can alter the antioxidant's efficacy or safety profile, necessitating extensive preclinical and clinical testing.

The heterogeneity of human diseases further complicates the clinical translation of antioxidants. Diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions involve distinct pathophysiological mechanisms, including varying roles of oxidative stress. As a result, an antioxidant that is effective in one disease context may not be beneficial in another, and in some cases, antioxidant therapy could potentially exacerbate disease progression by interfering with physiological ROS signaling pathways that are essential for normal cellular function [247, 248].

Clinical trials of antioxidants have also faced challenges related to dosing and endpoints [249, 250]. Determining the optimal dose of an antioxidant that provides therapeutic benefits without causing adverse effects is a complex process that requires careful consideration of the antioxidant's mechanism of action and pharmacokinetics. Furthermore, clinical trials must utilize relevant and measurable endpoints to assess the efficacy of antioxidant therapies, which can be difficult given the multifactorial nature of many diseases and the long latency periods before clinical outcomes manifest.

Lastly, the regulatory pathway for antioxidants, especially those derived from natural products, can be ambiguous and challenging. Demonstrating the safety and efficacy of these compounds to regulatory authorities requires a significant investment of time and resources, which can be a barrier for many researchers and companies [251].

Challenges and future perspectives

Limitations and obstacles in utilizing targeted antioxidants

Natural antioxidants have shown significant efficacy in the treatment of diseases such as diabetes and its complications, Alzheimer's disease, cancer, cardiovascular diseases, and inflammatory conditions. For instance, the natural antioxidant sulforaphane (SFN) activates transcription factors to help maintain cellular antioxidant defense systems and attenuate age-related changes [252]. Natural antioxidants may also contribute to controlling inflammatory responses, and certain antioxidant plant compounds can serve as targets for anti-inflammatory and antioxidant preventive strategies [253]. Despite their ability to prevent or repair cellular and tissue damage caused by oxidative stress, the application of natural antioxidants still faces several limitations and obstacles.

During oxidative stress, elevated levels of reactive oxygen species (ROS) can induce apoptosis in tumor cells, thereby inhibiting tumor growth and progression. However, antioxidants can neutralize free radicals and reduce oxidative stress, thereby mitigating the apoptotic tendency of tumor cells and promoting tumor progression. Glutathione (GSH) plays a dual role in tumor progression. On one hand, it is crucial for the elimination and detoxification of carcinogens, and alterations in this pathway can profoundly impact cell survival. However, high levels of GSH in tumor cells can protect them, leading to resistance against various chemotherapy drugs in bone marrow, breast, colon, throat, and lung cancers, thereby facilitating tumor development [254]. Furthermore, GSH helps maintain the balance of intracellular redox potential by preserving the reduced state of protein thiol groups, which is important in various pathological conditions, including cancer. On the other hand, GSH levels are closely associated with ROS. Moderate levels of ROS can promote survival and proliferation by activating signaling pathways that support tumor growth, particularly in the stressed tumor microenvironment. Wiel et al.'s study revealed that antioxidants such as N-acetylcysteine (NAC) and vitamin E promote KRAS-driven lung cancer metastasis by reducing free heme levels and stabilizing the transcription factor BACH1 [255]. BACH1 activation leads to increased transcription of Hexokinase 2 and Gapdh genes, enhancing glucose uptake, glycolytic rate, and lactate secretion, thereby stimulating the glycolysis-dependent metastasis of lung cancer cells. Preventing antioxidant-induced metastasis can be achieved by targeting BACH1 or its glycolytic targets, while increased endogenous BACH1 expression stimulates glycolysis and promotes metastasis, even in the absence of antioxidants. Antioxidants such as NAC and vitamin E reduce ROS levels, DNA damage, and p53 expression in both mouse and human lung tumor cells, promoting tumor cell proliferation [256].

The efficacy of antioxidants varies for different diseases and represents an important limitation. While antioxidants may help combat oxidative stress in diabetes and other diseases, excessive antioxidant activity may mask or interfere with necessary physiological signals in neurodegenerative diseases such as Alzheimer's disease and cerebrovascular diseases. Flavonoids, a class of natural antioxidants, can inhibit acetylcholinesterase and butyrylcholinesterase, prevent Tau protein aggregation, and modulate the activity of β-secretase [257]. Moreover, flavonoids exhibit antioxidant properties, attenuate oxidative stress, participate in anti-inflammatory processes, and prevent cell apoptosis by regulating signaling pathways associated with cognition and neuroprotection, such as ERK, PI3-kinase/Akt, NF-κB, and MAPKs [257]. Although antioxidants have demonstrated protective effects in animal models and in vitro experiments for Alzheimer's disease, clinical trial results have been less promising. Specifically, clinical trials with vitamin E, despite one study reporting delayed clinical deterioration in patients with moderate Alzheimer's disease using high-dose vitamin E, did not improve cognitive test scores [258]. This suggests that the effects of antioxidants in the human body may differ from those observed in experimental models, or other factors may influence their efficacy. A meta-analysis also indicated that vitamin E supplementation did not show beneficial effects in preventing any type of stroke, including ischemic stroke, hemorrhagic stroke, fatal stroke, and non-fatal stroke [259].

Currently, various natural antioxidants have entered clinical trial stages. For example, extracts from tea, cocoa, and numerous vegetables and fruits, including SFN, resveratrol, silymarin, alpha-tocopherol, and curcumin, activate oxidative stress signaling pathways and induce the production of antioxidant enzymes. Some of these antioxidants are being tested in clinical trials for the treatment and/or prevention of diseases [260–265]. These studies demonstrate the potential of natural antioxidants in medical applications. However, the therapeutic effects of natural antioxidants are still being investigated, and further research is needed to fully understand their mechanisms of action, optimal dosage, and potential interactions with other medications. Additionally, it is important to consider individual variations in response to antioxidants, as some individuals may benefit more from their use than others. Overall, while natural antioxidants hold promise for the treatment and prevention of various diseases, their application should be approached with caution and under the guidance of healthcare professionals.

Novel approaches and technologies in antioxidant research

With the continuous advancement of research on oxidative stress and antioxidants, new methods and technologies have emerged to explore and evaluate the potential and effects of antioxidants. Omics technologies encompass a set of approaches that study the overall composition and functionality of organisms at the molecular level, including genomics, transcriptomics, proteomics, and metabolomics. In antioxidant research, omics technologies are widely applied to gain in-depth understanding of the mechanisms, molecular basis, and biological effects of antioxidants. In antioxidant research, omics approaches can help identify genes associated with antioxidant reactions and cellular protection. On one hand, genomic and transcriptomic sequencing results can directly contribute to unraveling the genetic basis of plant antioxidant activity and evolution. Ren et al. identified antioxidant signaling pathway genes, such as Caffeoyl-CoA O-methyltransferase, anthocyanidin 3-O-glucosyltransferase, ( +)-neomenthol dehydrogenase, gibberellin 2-oxidase, and squalene monooxygenase, in Myrica rubra by examining 26,325 coding protein-coding genes, which exhibit multiple copies and regulate the content of flavonoids, anthocyanins, monoterpenoids, diterpenoids, and sesquiterpenoid/triterpenoids [266]. Researchers studying hippophaerhamnoides identified genes associated with ascorbic acid biosynthesis, such as GalLDH and GMPase, through a comparison of whole genome sequencing and transcriptomic analysis [267]. On the other hand, by comparing the gene profiles, transcript expression profiles, and metabolic profiles of antioxidant-treated groups and control groups, changes in gene expression related to antioxidant reactions can be discovered, revealing the regulatory effects of antioxidants on gene expression. This helps elucidate the impact of antioxidant treatment on intracellular signaling pathways, regulatory factors, and cell protection genes. A study utilizing transcriptomics and proteomics revealed the effects of SFN treatment and KEAP1 gene silencing on human breast epithelial cells (MCF10A), demonstrating similar expression patterns upregulating genes involved in detoxification and antioxidation processes, such as AKR1 family, NQO1, and ALDH3A1, providing a basis for the potential application of SFN as a chemopreventive agent for breast cancer [268].

Drug design and development face challenges such as low efficacy, off-target delivery, time consumption, and high costs. Complex data from genomics, proteomics, microarrays, and clinical trials further complicate the process. Here, artificial intelligence(AI) and deep learning play a crucial role in overcoming obstacles and improving drug discovery [269]. Computational methods, such as molecular docking and molecular dynamics simulations, are employed to predict the antioxidant activity of natural antioxidants. These methods provide insights into the molecular interactions between antioxidants and ROS, aiding in the optimization of natural antioxidants more effectively. Kumari Patial et al. evaluated the binding energies and interactions of phytosterols isolated from Araucaria columnaris with antioxidant enzymes peroxidase and hemoglobin oxidase through molecular docking calculations, validating the potential of phytosterols as antioxidants [270]. Zu et al. analyzed the stability of quercetin with three target proteins (MAPK1, TNF, and JUN) using molecular dynamics simulations [271]. Binding energy data obtained from mm/GBSA calculations showed the strongest binding energy between quercetin and TNF, followed by MAPK1, and JUN. Researchers have begun to fill the gap in antioxidant testing field using AI and machine learning (ML). The goal is to correlate the antioxidant activity of polyphenolic substances, such as those found in seeds, fruits, and vegetables, with their structural diversity. These polyphenolic substances exhibit different antioxidant mechanisms, including hydrogen atom transfer and single electron transfer [272]. By leveraging AI, scientists can develop more comprehensive experimental methods to reliably and comprehensively evaluate the health benefits of plant chemical substances [273]. Through ML, a predictive model can be established using antioxidant structural descriptors as input variables and their antioxidant activity in biological systems as output variables, thereby correlating and predicting the biologically relevant antioxidant capacity under different environments, enhancing the biological relevance of testing [274]. Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) techniques will aid in screening antioxidant peptides, primarily based on the three-dimensional structure of molecules [275]. Initially, three peptide sequences with free radical scavenging activity are collected, followed by structure construction and energy minimization. Subsequently, peptide alignment, modeling (e.g., CoMSIA method), and validation are conducted to analyze the contributions of various peptide properties to antioxidant activity, thereby identifying core fragments with excellent free radical scavenging capabilities [276].

Future Directions and Potential Applications in Precision Medicine

Antioxidants play a crucial role in maintaining cellular health by neutralizing harmful free radicals and reducing oxidative stress. As part of precision medicine, the application of antioxidants is an actively researched field. Here, we provide insights and potential future directions for the precision medicine of antioxidants. Antioxidant cocktails, which are therapeutic regimens composed of multiple antioxidants combined together, can achieve a synergistic effect and enhance overall antioxidant efficacy. This comprehensive treatment approach can be tailored to specific diseases, individual genotypes, lifestyles, and levels of oxidative stress [277]. A clinical trial has demonstrated that Antioxidant Cocktail therapy significantly reduces iron burden and oxidative stress in non-transfusion-dependent β-thalassemia/hemoglobin E patients, improves coagulation status, increases hemoglobin concentration, and enhances red blood cell quality [278]. In addition to tailoring antioxidant therapy based on an individual's level of oxidative stress, precision medicine can also determine the use of antioxidant mixtures as part of the treatment, as well as identify appropriate combinations and dosages based on genotype and other relevant factors. However, the effectiveness of Antioxidant Cocktail therapy in mitochondrial disease patients has not been clinically validated and there may be risks of inhibiting endogenous oxidants leading to cellular toxicity or toxicity. For rare diseases, individual susceptibility to the disease is often influenced by DNA sequence variations in one or a few genes. These variations can have a significant impact on disease manifestation. Understanding these monogenic variations is crucial in the context of antioxidant therapy. Certain genetic changes may affect an individual's response to antioxidants, thereby influencing their efficacy or potential side effects [279]. For example, the key transcription factor Nrf2 in the antioxidant defense system is targeted for degradation under normal conditions through its interaction with Keap1. However, under oxidative stress, modification of Keap1's sulfhydryl group leads to the release and activation of Nrf2, subsequently initiating the expression of a series of protective genes [280]. Studies have shown that SFN upregulates Nrf2-mediated antioxidant activity, reduces oxidative stress levels, and downregulates the transforming growth factor-beta 1 (TGF-β1)/Smad signaling pathway, thereby reducing extracellular matrix component expression and preventing radiation-induced muscle fibrosis [281]. This highlights the importance of Nrf2 in disease treatment and potential drug development. Integrating large-scale biomedical data, including genetic information, oxidative stress markers, lifestyle factors, and treatment outcomes, provides an opportunity to develop predictive models using ML algorithms. These models can help identify individuals who are more susceptible to oxidative stress-related diseases and predict their response to antioxidant interventions. Such predictive models can support the decision-making process for personalized antioxidant therapy and contribute to improving treatment outcomes for patients.

Conclusion

Summary of key findings and implications

This review mainly discusses the application effect of targeted antioxidant natural products in different diseases. Studies have found that antioxidant natural products improve oxidative stress damage in cells through a variety of mechanisms, thereby treating and improving disease. Studies have found that antioxidant natural products have potential efficacy in cardiovascular diseases, neurological diseases, obesity and insulin resistance, cancer, metabolic diseases, and skin aging, as well as the ability to regulate the immune system and anti-inflammatory processes. Studies have confirmed that some antioxidant natural products can prevent and treat cardiovascular disease through different mechanisms of action, such as lowering blood pressure, regulating lipid distribution, improving oxidative stress, reducing inflammation, and regulating gut microbiota [282]. Excessive production of reactive oxygen species and decreased antioxidant capacity in nerve cells cause oxidative stress, leading to the emergence of neurodegenerative diseases. The brain has a high concentration of fatty acids, high oxygen demand, weak antioxidant capacity and sensitivity to oxidative damage. Some antioxidant natural products can reduce oxidative damage and improve the endogenous antioxidant capacity of cells by acting inside and outside the cell, so as to prevent and slow down the occurrence of nervous system diseases [283]. Experiments have confirmed that the diet of vegetables and fruits reduces the metabolic products of oxidative stress in patients with metabolic diseases, including obesity and diabetes, which may be related to the natural antioxidant bioactive compounds present in vegetables and fruits [284, 285]. Excessive reactive oxygen species in cells break the balance of pro-oxidation and antioxidant, cause oxidative stress, induce cell damage, DNA mutation, abnormal cell proliferation, and thus cancer [286, 287]. Natural antioxidants such as flavonoids obtained from the diet have the potential to scavenge free radicals, inhibit superoxide-producing enzymes, and increase antioxidant activity to inhibit the development of cancer [288, 289]. Skin, as the largest organ of the human body, is vulnerable to external ultraviolet rays, toxic substances and pollution, resulting in skin health problems, especially skin aging, the most concerned. Both internal and external aging are related to the production of free radicals and the oxidative stress of the skin, so some antioxidant natural products play a key role in delaying aging and promoting skin health [290, 291]. Immune system regulation and inflammatory diseases are closely related to changes in ROS levels. Moderate ROS levels contribute to immune regulation and anti-inflammatory processes, while high ROS levels can damage the immune system and lead to the development of inflammation [292]. Animal experiments have shown that curcumin and chitosan can effectively promote wound healing, which may be related to its anti-inflammatory effect [293].

Although a large number of experiments have confirmed that targeted antioxidant natural products can be used to treat oxidative stress, there are still limitations and obstacles. Issues include specificity, administration and bioavailability, dose and concentration, selectivity, complexity of oxidative stress pathways, lack of comprehensive understanding, and cost and availability. Addressing these issues will require further research, technological advances, and a comprehensive understanding of the biology of oxidative stress [294].

Final thoughts on the role of targeted antioxidant natural products in therapeutics

The therapeutic effects of targeted antioxidant natural products are widely discussed and researched. Antioxidants play a crucial role in maintaining cellular health by neutralizing harmful free radicals and reducing oxidative stress [295]. Several diseases are associated with oxidative stress, including cardiovascular diseases, COPD, neurodegenerative diseases, metabolic disorders, cancer, and aging. Natural products such as vitamins (C and E), polyphenolic compounds (such as resveratrol and curcumin), and carotenoids (such as β-carotene) have gained attention for their antioxidant properties and are widely found in fruits, vegetables, nuts, and other plants [296].

Some preclinical studies and preliminary clinical trials have shown potential positive effects of targeted antioxidant natural products on certain diseases. For example, vitamin C has demonstrated potential in reducing the risk of cardiovascular diseases and certain cancers, resveratrol has shown potential in protecting against age-related diseases and promoting longevity, and curcumin has exhibited anti-inflammatory and anticancer properties [297–300]. However, the overall clinical evidence for the therapeutic use of targeted antioxidant natural products remains limited and often contradictory. Their effects are influenced by various factors, including specific diseases, dosage, duration of treatment, and individual patient characteristics [301]. Additionally, the bioavailability and metabolism of these compounds may vary, affecting their effectiveness in the body.

Recent research has also highlighted that excessive use of high-dose antioxidant supplements may not always be beneficial and can even lead to adverse reactions. Overconsumption of antioxidants may interfere with the body's natural defense mechanisms against oxidative stress, thereby weakening the body's ability to combat diseases [302]. Therefore, caution should be exercised when applying targeted antioxidant natural products, and further research is needed. Well-designed clinical trials can help evaluate their safety, efficacy, optimal dosage, and potential interactions with other medications. Furthermore, adopting a comprehensive approach to health, including a balanced diet rich in antioxidants, may be more beneficial than solely relying on antioxidant supplements [303].

In conclusion, targeted antioxidant natural products have the potential to play a significant role in therapy, but their exact benefits and limitations require further investigation. It is necessary to deepen our understanding of their mechanisms of action, optimal application methods, and potential risks in order to better harness the potential of these natural products for improving human health.

Abbreviations

Aβ Amyloid-beta

AMP Activated protein kinase (AMPK)

ALS Amyotrophic lateral sclerosis

AKR1 Family Aldo–keto reductase family 1

ALDH3A1 Aldehyde dehydrogenase 3A1

AI Artificial intelligence

AMPK Adenosine monophosphate-activated protein kinase

AMPK: Adenosine monophosphate-activated protein kinase

BACH1 Bacillus amyloliquefaciens H 1

CAT Catalase

CVDs Cardio vascular diseases

COX-2 Cyclooxygenase-2

CCoAOMT Caffeoyl coenzyme A O-methyltransferase

DHA Docosahexaenoic acid

DPPH 2,2-Diphenyl-1-picrylhydrazyl

EPA Eicosapentaenoic acid

GSHPx Glutathione peroxidase

GSH Glutathione

GBSA calculations Generalised born and surface area solvation

GalLDH L-galactono-1,4-lactone dehydrogenase

GMPase GDP-D-mannose pyrophosphorylase

HDL High-density lipoprotein

KRAS Driven lung cancer metastasis Kirsten rat sarcoma viral oncogene homolog.

LDL Low-density lipoproteins

MAPK Mitogen-activated protein kinase

ML Machine learning

MS Multiple sclerosis

NAC N-acetylcysteine

NFκB Nuclear factor kappa B

NQO1 NAD(P)H dehydrogenase [quinone] 1

Nrf2 Nuclear factor erythroid 2-related factor 2

ORAC Oxygen radical absorbance capacity

PD Parkinson's disease

PI3K Phosphoinositide 3-kinase

PKC Protein kinase C

ROS Reactive oxygen species

RNS Reactive nitrogen species

SFN Sulforaphane

SIRT-1 Sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)

SIRT-CVS Short interval resveratrol trial in cardiovascular surgery

SOD Superoxide dismutase

VEGF Vascular endothelial growth factor

WHO World health organization

Author contributions

S. M., R.G.: Writing original draft and conceptualization, R.G., S.J.: Data Collection, Visualization and writing original draft, Z.D., T.D. Supervision and review editing, H.C., T.B.: Supervision, Data validation, Review and editing.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Competing  interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Lobo V Patil A Phatak A Chandra N Free radicals, antioxidants and functional foods: Impact on human health Pharmacogn Rev 2010 4 118 10.4103/0973-7847.70902 22228951
Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4:118.22228951 10.4103/0973-7847.70902
2. Forman HJ Zhang H Targeting oxidative stress in disease: promise and limitations of antioxidant therapy Nat Rev Drug Discov 2021 20 689 709 10.1038/s41573-021-00233-1 34194012
Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20:689–709.34194012 10.1038/s41573-021-00233-1
3. Yuan H Ma Q Ye L Piao G The traditional medicine and modern medicine from natural products Molecules 2016 10.3390/molecules21050559 28042867
Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016. 10.3390/molecules21050559.28042867 10.3390/molecules21050559
4. Integrating Traditional Medicine in Health Care Available online: https://www.who.int/southeastasia/news/feature-stories/detail/integrating-traditional-medicine (accessed on 8 March 2024).
5. Goyal R Mittal G Khurana S Malik N Kumar V Soni A Chopra H Kamal MA Insights on quercetin therapeutic potential for neurodegenerative diseases and its nano-technological perspectives Curr Pharm Biotechnol 2023 10.2174/1389201025666230830125410 37550917
Goyal R, Mittal G, Khurana S, Malik N, Kumar V, Soni A, Chopra H, Kamal MA. Insights on quercetin therapeutic potential for neurodegenerative diseases and its nano-technological perspectives. Curr Pharm Biotechnol. 2023. 10.2174/1389201025666230830125410.37550917 10.2174/1389201025666230830125410
6. Chopra H Sharma S Yousaf S Naseer R Ahmed S Baig AA Applications of nanotechnology-based approaches for targeted delivery of nutraceuticals Handb Nanotechnol Nutraceuticals 2022 10.1201/9781003244721-12/APPLICATIONS-NANOTECHNOLOGY-BASED-APPROACHES-TARGETED-DELIVERY-NUTRACEUTICALS-HITESH-CHOPRA-SHIVANI-SHARMA-SABA-YOUSAF-RAHAT-NASEER-SHAKEEL-AHMED-ATIF-AMIN-BAIG
Chopra H, Sharma S, Yousaf S, Naseer R, Ahmed S, Baig AA. Applications of nanotechnology-based approaches for targeted delivery of nutraceuticals. Handb Nanotechnol Nutraceuticals. 2022. 10.1201/9781003244721-12.10.1201/9781003244721-12/APPLICATIONS-NANOTECHNOLOGY-BASED-APPROACHES-TARGETED-DELIVERY-NUTRACEUTICALS-HITESH-CHOPRA-SHIVANI-SHARMA-SABA-YOUSAF-RAHAT-NASEER-SHAKEEL-AHMED-ATIF-AMIN-BAIG
7. Walia V Kaushik D Mittal V Kumar K Verma R Parashar J Akter R Rahman MHMH Bhatia S Al-Harrasi A Delineation of neuroprotective effects and possible benefits of antioxidantstherapy for the treatment of Alzheimer’s diseases by targeting mitochondrial-derived reactive oxygen species: bench to bedside Mol Neurobiol 2022 59 657 680 10.1007/s12035-021-02617-1 34751889
Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J, Akter R, Rahman MHMH, Bhatia S, Al-Harrasi A, et al. Delineation of neuroprotective effects and possible benefits of antioxidantstherapy for the treatment of Alzheimer’s diseases by targeting mitochondrial-derived reactive oxygen species: bench to bedside. Mol Neurobiol. 2022;59:657–80. 10.1007/s12035-021-02617-1.34751889 10.1007/s12035-021-02617-1
8. Zehiroglu C Ozturk Sarikaya SB The importance of antioxidants and place in today’s scientific and technological studies J Food Sci Technol 2019 56 4757 4774 10.1007/s13197-019-03952-x 31741500
Zehiroglu C, Ozturk Sarikaya SB. The importance of antioxidants and place in today’s scientific and technological studies. J Food Sci Technol. 2019;56:4757–74.31741500 10.1007/s13197-019-03952-x
9. Kotha RR Tareq FS Yildiz E Luthria DL Oxidative stress and antioxidants—a critical review on in vitro antioxidant assays Antioxidants 2022 11 2388 10.3390/antiox11122388 36552596
Kotha RR, Tareq FS, Yildiz E, Luthria DL. Oxidative stress and antioxidants—a critical review on in vitro antioxidant assays. Antioxidants. 2022;11:2388.36552596 10.3390/antiox11122388
10. Birben E Sahiner UM Sackesen C Erzurum S Kalayci O Oxidative stress and antioxidant defense World Allergy Organ J 2012 5 9 19 10.1097/WOX.0b013e3182439613 23268465
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5:9–19.23268465 10.1097/WOX.0b013e3182439613
11. Poljsak B Strategies for reducing or preventing the generation of oxidative stress Oxid Med Cell Longev 2011 2011 1 194586 22191011
Poljsak B. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev. 2011;2011(1): 194586.22191011
12. Jena AB Samal RR Bhol NK Duttaroy AK Cellular red-ox system in health and disease: the latest update Biomed Pharmacother 2023 162 114606 10.1016/j.biopha.2023.114606 36989716
Jena AB, Samal RR, Bhol NK, Duttaroy AK. Cellular red-ox system in health and disease: the latest update. Biomed Pharmacother. 2023;162:114606.36989716 10.1016/j.biopha.2023.114606
13. Lee SE Park YS The emerging roles of antioxidant enzymes by dietary phytochemicals in vascular diseases Life 2021 11 199 10.3390/life11030199 33806594
Lee SE, Park YS. The emerging roles of antioxidant enzymes by dietary phytochemicals in vascular diseases. Life. 2021;11:199.33806594 10.3390/life11030199
14. Apak R Özyürek M Güçlü K Çapanoʇlu E Antioxidant activity/capacity measurement 1 classification, physicochemical principles, mechanisms, and electron transfer (ET)-based assays J Agric Food Chem 2016 64 997 1027 10.1021/acs.jafc.5b04739 26728425
Apak R, Özyürek M, Güçlü K, Çapanoʇlu E. Antioxidant activity/capacity measurement 1 classification, physicochemical principles, mechanisms, and electron transfer (ET)-based assays. J Agric Food Chem. 2016;64:997–1027.26728425 10.1021/acs.jafc.5b04739
15. Darenskaya M Kolesnikov S Semenova N Kolesnikova L Diabetic nephropathy: significance of determining oxidative stress and opportunities for antioxidant therapies Int J Mol Sci 2023 24 12378 10.3390/ijms241512378 37569752
Darenskaya M, Kolesnikov S, Semenova N, Kolesnikova L. Diabetic nephropathy: significance of determining oxidative stress and opportunities for antioxidant therapies. Int J Mol Sci. 2023;24:12378.37569752 10.3390/ijms241512378
16. Ahmad KA Yuan Yuan D Nawaz W Ze H Zhuo CX Talal B Taleb A Mais E Qilong D Antioxidant therapy for management of oxidative stress induced hypertension Free Radic Res 2017 51 428 438 10.1080/10715762.2017.1322205 28427291
Ahmad KA, Yuan Yuan D, Nawaz W, Ze H, Zhuo CX, Talal B, Taleb A, Mais E, Qilong D. Antioxidant therapy for management of oxidative stress induced hypertension. Free Radic Res. 2017;51:428–38.28427291 10.1080/10715762.2017.1322205
17. Feng Y Wang X Antioxidant therapies for Alzheimer’s disease Oxid Med Cell Longev 2012 2012 1 472932 22888398
Feng Y, Wang X. Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev. 2012;2012(1): 472932.22888398
18. Moura FA de Andrade KQ dos Santos JCF Araújo ORP Goulart MOF Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol 2015 6 617 639 10.1016/j.redox.2015.10.006 26520808
Moura FA, de Andrade KQ, dos Santos JCF, Araújo ORP, Goulart MOF. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol. 2015;6:617–39.26520808 10.1016/j.redox.2015.10.006
19. Luo M Zhou L Huang Z Li B Nice EC Xu J Huang C Antioxidant therapy in cancer: rationale and progress Antioxidants 2022 11 1128 10.3390/antiox11061128 35740025
Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, Huang C. Antioxidant therapy in cancer: rationale and progress. Antioxidants. 2022;11:1128.35740025 10.3390/antiox11061128
20. Teleanu RI Chircov C Grumezescu AM Volceanov A Teleanu DM Antioxidant therapies for neuroprotection-a review J Clin Med 2019 8 1659 10.3390/jcm8101659 31614572
Teleanu RI, Chircov C, Grumezescu AM, Volceanov A, Teleanu DM. Antioxidant therapies for neuroprotection-a review. J Clin Med. 2019;8:1659.31614572 10.3390/jcm8101659
21. Collins AE Saleh TM Kalisch BE Naturally occurring antioxidant therapy in Alzheimer’s disease Antioxidants 2022 11 213 10.3390/antiox11020213 35204096
Collins AE, Saleh TM, Kalisch BE. Naturally occurring antioxidant therapy in Alzheimer’s disease. Antioxidants. 2022;11:213.35204096 10.3390/antiox11020213
22. Wang S Teng H Zhang L Wu L Association between dietary antioxidant intakes and chronic respiratory diseases in adults World Allergy Organ J 2024 17 100851 10.1016/j.waojou.2023.100851 38259299
Wang S, Teng H, Zhang L, Wu L. Association between dietary antioxidant intakes and chronic respiratory diseases in adults. World Allergy Organ J. 2024;17: 100851. 10.1016/j.waojou.2023.100851.38259299 10.1016/j.waojou.2023.100851
23. Vidavalur R Otani H Singal PK Maulik N Significance of wine and resveratrol in cardiovascular disease: French paradox revisited Exp Clin Cardiol 2006 11 217 225 18651034
Vidavalur R, Otani H, Singal PK, Maulik N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol. 2006;11:217–25.18651034
24. Li H Xia N Hasselwander S Daiber A Resveratrol and vascular function Int J Mol Sci 2019 10.3390/ijms20092155 31906256
Li H, Xia N, Hasselwander S, Daiber A. Resveratrol and vascular function. Int J Mol Sci. 2019. 10.3390/ijms20092155.31906256 10.3390/ijms20092155
25. Chaplin A Carpéné C Mercader J Resveratrol, metabolic syndrome, and gut microbiota Nutrients 2018 10.3390/nu10111651 30400297
Chaplin A, Carpéné C, Mercader J. Resveratrol, metabolic syndrome, and gut microbiota. Nutrients. 2018. 10.3390/nu10111651.30400297 10.3390/nu10111651
26. Jang JY Im E Kim ND Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review Int J Mol Sci 2022 10.3390/ijms232213689 36614125
Jang JY, Im E, Kim ND. Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review. Int J Mol Sci. 2022. 10.3390/ijms232213689.36614125 10.3390/ijms232213689
27. Almatroodi SA A Alsahli M SM Aljohani A Alhumaydhi FA Babiker AY Khan AA Rahmani AH Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer Molecules 2022 27 9 2665 10.3390/molecules27092665 35566016
Almatroodi SA, A Alsahli M, SM Aljohani A, Alhumaydhi FA, Babiker AY, Khan AA, Rahmani AH. Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer. Molecules. 2022;27(9):2665.35566016 10.3390/molecules27092665
28. Izzo C Annunziata M Melara G Sciorio R Dallio M Masarone M Federico A Persico M The role of resveratrol in liver disease: a comprehensive review from in vitro to clinical trials Nutrients 2021 10.3390/nu13030933 34959920
Izzo C, Annunziata M, Melara G, Sciorio R, Dallio M, Masarone M, Federico A, Persico M. The role of resveratrol in liver disease: a comprehensive review from in vitro to clinical trials. Nutrients. 2021. 10.3390/nu13030933.34959920 10.3390/nu13030933
29. Nashine S Nesburn AB Kuppermann BD Kenney MC Role of resveratrol in transmitochondrial AMD RPE cells Nutrients 2020 10.3390/nu12010159 31935891
Nashine S, Nesburn AB, Kuppermann BD, Kenney MC. Role of resveratrol in transmitochondrial AMD RPE cells. Nutrients. 2020. 10.3390/nu12010159.31935891 10.3390/nu12010159
30. Dyck GJB Raj P Zieroth S Dyck JRB Ezekowitz JA The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review Int J Mol Sci 2019 10.3390/ijms20040904 30791450
Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA. The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review. Int J Mol Sci. 2019. 10.3390/ijms20040904.30791450 10.3390/ijms20040904
31. Prysyazhna O Wolhuter K Switzer C Santos C Yang X Lynham S Shah AM Eaton P Burgoyne JR Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of CGMP-dependent protein kinase Circulation 2019 140 126 137 10.1161/CIRCULATIONAHA.118.037398 31116951
Prysyazhna O, Wolhuter K, Switzer C, Santos C, Yang X, Lynham S, Shah AM, Eaton P, Burgoyne JR. Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of CGMP-dependent protein kinase. Circulation. 2019;140:126–37. 10.1161/CIRCULATIONAHA.118.037398.31116951 10.1161/CIRCULATIONAHA.118.037398
32. Movahed A Ostovar A Iranpour D Thandapilly SJ Raj P Louis XL Smoliga JM Netticadan T The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded Placebo-Controlled Trial Trials 2016 17 296 10.1186/s13063-016-1426-x 27339453
Movahed A, Ostovar A, Iranpour D, Thandapilly SJ, Raj P, Louis XL, Smoliga JM, Netticadan T. The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded. Placebo-Controlled Trial Trials. 2016;17:296. 10.1186/s13063-016-1426-x.27339453 10.1186/s13063-016-1426-x
33. Theodotou M Fokianos K Mouzouridou A Konstantinou C Aristotelous A Prodromou D Chrysikou A The effect of resveratrol on hypertension: a clinical trial Exp Ther Med 2017 13 295 301 10.3892/etm.2016.3958 28123505
Theodotou M, Fokianos K, Mouzouridou A, Konstantinou C, Aristotelous A, Prodromou D, Chrysikou A. The effect of resveratrol on hypertension: a clinical trial. Exp Ther Med. 2017;13:295–301. 10.3892/etm.2016.3958.28123505 10.3892/etm.2016.3958
34. Fogacci F Tocci G Presta V Fratter A Borghi C Cicero AFG Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials Crit Rev Food Sci Nutr 2019 59 1605 1618 10.1080/10408398.2017.1422480 29359958
Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AFG. Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr. 2019;59:1605–18. 10.1080/10408398.2017.1422480.29359958 10.1080/10408398.2017.1422480
35. Short Interval Resveratrol Trial in Cardiovascular Surgery - Full Text View - ClinicalTrials.Gov Available online: https://classic.clinicaltrials.gov/ct2/show/NCT03762096 (accessed on 9 March 2024).
36. Cardiovascular Health of Older Adults and Resveratrol (CORE) - Full Text View - ClinicalTrials.Gov Available online: https://classic.clinicaltrials.gov/ct2/show/NCT02909699 (accessed on 9 March 2024).
37. Gal R Deres L Toth K Halmosi R Habon T The effect of resveratrol on the cardiovascular system from molecular mechanisms to clinical results Int J Mol Sci 2021 22 10152 10.3390/ijms221810152 34576315
Gal R, Deres L, Toth K, Halmosi R, Habon T. The effect of resveratrol on the cardiovascular system from molecular mechanisms to clinical results. Int J Mol Sci. 2021;22:10152.34576315 10.3390/ijms221810152
38. Zhu N Huang B Jiang W Targets of vitamin C with therapeutic potential for cardiovascular disease and underlying mechanisms: a study of network pharmacology Front Pharmacol 2021 11 591337 10.3389/fphar.2020.591337 33603661
Zhu N, Huang B, Jiang W. Targets of vitamin C with therapeutic potential for cardiovascular disease and underlying mechanisms: a study of network pharmacology. Front Pharmacol. 2021;11:591337.33603661 10.3389/fphar.2020.591337
39. Moser MA Chun OK Vitamin C and heart health: a review based on findings from epidemiologic studies Int J Mol Sci 2016 10.3390/ijms17081328 27529239
Moser MA, Chun OK. Vitamin C and heart health: a review based on findings from epidemiologic studies. Int J Mol Sci. 2016. 10.3390/ijms17081328.27529239 10.3390/ijms17081328
40. Morelli MB Gambardella J Castellanos V Trimarco V Santulli G Vitamin C and cardiovascular disease: an update Antioxidants (Basel Switzerland) 2020 10.3390/antiox9121227 33287462
Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G. Vitamin C and cardiovascular disease: an update. Antioxidants (Basel Switzerland). 2020. 10.3390/antiox9121227.33287462 10.3390/antiox9121227
41. Cardiovascular Health Through Vitamin C Intake - PCNA Available online: https://pcna.net/cardiovascular-health-through-vitamin-c-intake/ (accessed on 9 March 2024).
42. High Dose Vitamin C in Cardiac Surgery Patients - Full Text View - ClinicalTrials.Gov Available online: https://classic.clinicaltrials.gov/ct2/show/NCT02762331 (accessed on 9 March 2024).
43. Vitamin C in Cardiac Surgery Patients - Full Text View - ClinicalTrials.Gov Available online: https://classic.clinicaltrials.gov/ct2/show/NCT03123107 (accessed on 9 March 2024).
44. Rozemeijer S de Grooth HJ Elbers PWG Girbes ARJ den Uil CA Dubois EA Wils EJ Rettig TCD van Zanten ARH Vink R Early high-dose vitamin c in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center Placebo-Controlled Trial Trials 2021 10.1186/s13063-021-05483-3 34407846
Rozemeijer S, de Grooth HJ, Elbers PWG, Girbes ARJ, den Uil CA, Dubois EA, Wils EJ, Rettig TCD, van Zanten ARH, Vink R, et al. Early high-dose vitamin c in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center. Placebo-Controlled Trial Trials. 2021. 10.1186/s13063-021-05483-3.34407846 10.1186/s13063-021-05483-3
45. Can Vitamins Help Prevent a Heart Attack? - Mayo Clinic Available online: https://www.mayoclinic.org/diseases-conditions/heart-disease/expert-answers/prevent-heart-attack/faq-20058253 (accessed on 9 March 2024).
46. Shah S Shiekh Y Lawrence JA Ezekwueme F Alam M Kunwar S Gordon DK A systematic review of effects of vitamin E on the cardiovascular system Cureus 2021 10.7759/cureus.15616 35111439
Shah S, Shiekh Y, Lawrence JA, Ezekwueme F, Alam M, Kunwar S, Gordon DK. A systematic review of effects of vitamin E on the cardiovascular system. Cureus. 2021. 10.7759/cureus.15616.35111439 10.7759/cureus.15616
47. Rychter AM Hryhorowicz S Słomski R Dobrowolska A Krela-Kaźmierczak I Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity – a narrative review Clin Nutr 2022 41 1557 1565 10.1016/j.clnu.2022.04.032 35667272
Rychter AM, Hryhorowicz S, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity – a narrative review. Clin Nutr. 2022;41:1557–65.35667272 10.1016/j.clnu.2022.04.032
48. Yusuf S Dagenais G Pogue J Bosch J Sleight P Vitamin E supplementation and cardiovascular events in high-risk patients. the heart outcomes prevention evaluation study investigators N Engl J Med 2000 342 154 160 10.1056/NEJM200001203420302 10639540
Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. the heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342:154–60.10639540 10.1056/NEJM200001203420302
49. Lee IM Cook NR Gaziano JM Gordon D Ridker PM Manson JAE Hennekens CH Buring JE Vitamin E in the primary prevention of cardiovascular disease and cancer the women’s health study: a randomized controlled trial JAMA 2005 10.1001/jama.294.1.56 16278359
Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JAE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer the women’s health study: a randomized controlled trial. JAMA. 2005. 10.1001/jama.294.1.56.16278359 10.1001/jama.294.1.56
50. Saremi A Arora R Vitamin E and cardiovascular disease Am J Ther 2010 17 e56 65 10.1097/MJT.0b013e31819cdc9a 19451807
Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J Ther. 2010;17:e56-65. 10.1097/MJT.0b013e31819cdc9a.19451807 10.1097/MJT.0b013e31819cdc9a
51. Wang M Tang R Zhou R Qian Y Di D The protective effect of serum carotenoids on cardiovascular disease: a cross-sectional study from the general US adult population Front Nutr 2023 10.3389/fnut.2023.1154239 38370980
Wang M, Tang R, Zhou R, Qian Y, Di D. The protective effect of serum carotenoids on cardiovascular disease: a cross-sectional study from the general US adult population. Front Nutr. 2023. 10.3389/fnut.2023.1154239.38370980 10.3389/fnut.2023.1154239
52. Yang J Zhang Y Na X Zhao A β-carotene supplementation and risk of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials Nutrients 2022 14 1284 10.3390/nu14061284 35334942
Yang J, Zhang Y, Na X, Zhao A. β-carotene supplementation and risk of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022;14:1284.35334942 10.3390/nu14061284
53. Tavani A La Vecchia C β-Carotene and risk of coronary heart disease a review of observational and intervention studies Biomed Pharmacother 1999 10.1016/S0753-3322(99)80120-6 10554676
Tavani A, La Vecchia C. β-Carotene and risk of coronary heart disease a review of observational and intervention studies. Biomed Pharmacother. 1999. 10.1016/S0753-3322(99)80120-6.10554676 10.1016/S0753-3322(99)80120-6
54. Cardona F Andrés-Lacueva C Tulipani S Tinahones FJ Queipo-Ortuño MI Benefits of polyphenols on gut microbiota and implications in human health J Nutr Biochem 2013 24 1415 1422 10.1016/j.jnutbio.2013.05.001 23849454
Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24:1415–22.23849454 10.1016/j.jnutbio.2013.05.001
55. Cooper KA Chopra M Thurnham DI Wine polyphenols and promotion of cardiac health Nutr Res Rev 2004 10.1079/nrr200482 19079920
Cooper KA, Chopra M, Thurnham DI. Wine polyphenols and promotion of cardiac health. Nutr Res Rev. 2004. 10.1079/nrr200482.19079920 10.1079/nrr200482
56. Börzsei D Sebestyén J Szabó R Lesi ZN Pálszabó A Pálszabó P Szász A Priksz D Juhász B Veszelka M Resveratrol as a promising polyphenol in age-associated cardiac alterations Oxid Med Cell Longev 2022 10.1155/2022/7911222 35761875
Börzsei D, Sebestyén J, Szabó R, Lesi ZN, Pálszabó A, Pálszabó P, Szász A, Priksz D, Juhász B, Veszelka M, et al. Resveratrol as a promising polyphenol in age-associated cardiac alterations. Oxid Med Cell Longev. 2022. 10.1155/2022/7911222.35761875 10.1155/2022/7911222
57. Sari N Katanasaka Y Honda H Miyazaki Y Sunagawa Y Funamoto M Shimizu K Shimizu S Wada H Hasegawa K Cacao bean polyphenols inhibit cardiac hypertrophy and systolic dysfunction in pressure overload-induced heart failure model mice Planta Med 2020 10.1055/a-1191-7970 32645737
Sari N, Katanasaka Y, Honda H, Miyazaki Y, Sunagawa Y, Funamoto M, Shimizu K, Shimizu S, Wada H, Hasegawa K, et al. Cacao bean polyphenols inhibit cardiac hypertrophy and systolic dysfunction in pressure overload-induced heart failure model mice. Planta Med. 2020. 10.1055/a-1191-7970.32645737 10.1055/a-1191-7970
58. Tangney CC Rasmussen HE Polyphenols, inflammation, and cardiovascular disease Curr Atheroscler Rep 2013 10.1007/s11883-013-0324-x 23512608
Tangney CC, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 2013. 10.1007/s11883-013-0324-x.23512608 10.1007/s11883-013-0324-x
59. Khurana S Venkataraman K Hollingsworth A Piche M Tai TC Polyphenols: benefits to the cardiovascular system in health and in aging Nutrients 2013 5 3779 3827 10.3390/nu5103779 24077237
Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013;5:3779–827.24077237 10.3390/nu5103779
60. Hedayati N Yaghoobi A Salami M Gholinezhad Y Aghadavood F Eshraghi R Aarabi MH Homayoonfal M Asemi Z Mirzaei H Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms Front Cardiovasc Med 2023 10 1174816 10.3389/fcvm.2023.1174816 37293283
Hedayati N, Yaghoobi A, Salami M, Gholinezhad Y, Aghadavood F, Eshraghi R, Aarabi MH, Homayoonfal M, Asemi Z, Mirzaei H, et al. Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms. Front Cardiovasc Med. 2023;10:1174816.37293283 10.3389/fcvm.2023.1174816
61. Behl T Bungau S Kumar K Zengin G Khan F Kumar A Kaur R Venkatachalam T Tit DM Vesa CM Pleotropic effects of polyphenols in cardiovascular system Biomed Pharmacother 2020 130 110714 10.1016/j.biopha.2020.110714 34321158
Behl T, Bungau S, Kumar K, Zengin G, Khan F, Kumar A, Kaur R, Venkatachalam T, Tit DM, Vesa CM, et al. Pleotropic effects of polyphenols in cardiovascular system. Biomed Pharmacother. 2020;130:110714.34321158 10.1016/j.biopha.2020.110714
62. Chopra H Bibi S Mohanta YK Kumari S Baig AA Role of polyphenols in cardiovascular diseases in bioprospecting of tropical medicinal plants 2023 Cham Springer
Chopra H, Bibi S, Mohanta YK, Kumari S, Baig AA. Role of polyphenols in cardiovascular diseases in bioprospecting of tropical medicinal plants. Cham: Springer; 2023.
63. Goszcz K Duthie GG Stewart D Leslie SJ Megson IL Bioactive polyphenols and cardiovascular disease: Chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response? Br J Pharmacol 2017 174 1209 1225 10.1111/bph.13708 28071785
Goszcz K, Duthie GG, Stewart D, Leslie SJ, Megson IL. Bioactive polyphenols and cardiovascular disease: Chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response? Br J Pharmacol. 2017;174:1209–25.28071785 10.1111/bph.13708
64. Khan J Deb PK Priya S Medina KD Devi R Walode SG Rudrapal M Dietary flavonoids: cardioprotective potential with antioxidant effects and their pharmacokinetic Toxicological and Therapeutic Concerns Molecules 2021 26 4021 10.3390/molecules26134021 34209338
Khan J, Deb PK, Priya S, Medina KD, Devi R, Walode SG, Rudrapal M. Dietary flavonoids: cardioprotective potential with antioxidant effects and their pharmacokinetic Toxicological and Therapeutic Concerns. Molecules. 2021;26:4021.34209338 10.3390/molecules26134021
65. Jubaidi FF Zainalabidin S Taib IS Hamid ZA Budin SB The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis Int J Mol Sci 2021 10.3390/ijms22105094 34769045
Jubaidi FF, Zainalabidin S, Taib IS, Hamid ZA, Budin SB. The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. Int J Mol Sci. 2021. 10.3390/ijms22105094.34769045 10.3390/ijms22105094
66. Suen, J.; Thomas, J.; Kranz, A.; Vun, S.; Miller, M. Effect of Flavonoids on Oxidative Stress and Inflammation in Adults at Risk of Cardiovascular Disease: A Systematic Review. Healthc. 2016, 4.
67. Ciumărnean L Milaciu MV Runcan O Vesa SC Răchisan AL Negrean V Perné MG Donca VI Alexescu TG Para I The effects of flavonoids in cardiovascular diseases Molecules 2020 25 4320 10.3390/molecules25184320 32967119
Ciumărnean L, Milaciu MV, Runcan O, Vesa SC, Răchisan AL, Negrean V, Perné MG, Donca VI, Alexescu TG, Para I, et al. The effects of flavonoids in cardiovascular diseases. Molecules. 2020;25:4320.32967119 10.3390/molecules25184320
68. Yan Q Liu S Sun Y Chen C Yang S Lin M Long J Yao J Lin Y Yi F Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease J Transl Med 2023 21 519 10.1186/s12967-023-04361-7 37533007
Yan Q, Liu S, Sun Y, Chen C, Yang S, Lin M, Long J, Yao J, Lin Y, Yi F, et al. Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease. J Transl Med. 2023;21:519.37533007 10.1186/s12967-023-04361-7
69. Mattioli R Francioso A Mosca L Silva P Anthocyanins: a comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases Molecules 2020 25 3809 10.3390/molecules25173809 32825684
Mattioli R, Francioso A, Mosca L, Silva P. Anthocyanins: a comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases. Molecules. 2020;25:3809.32825684 10.3390/molecules25173809
70. Mozos I Flangea C Vlad DC Gug C Mozos C Stoian D Luca CT Horbańczuk JO Horbańczuk OK Atanasov AG Effects of anthocyanins on vascular health Biomolecules 2021 11 811 10.3390/biom11060811 34070757
Mozos I, Flangea C, Vlad DC, Gug C, Mozos C, Stoian D, Luca CT, Horbańczuk JO, Horbańczuk OK, Atanasov AG. Effects of anthocyanins on vascular health. Biomolecules. 2021;11:811.34070757 10.3390/biom11060811
71. Grassi D Desideri G Ferri C Flavonoids: antioxidants against atherosclerosis Nutrients 2010 2 889 902 10.3390/nu2080889 22254061
Grassi D, Desideri G, Ferri C. Flavonoids: antioxidants against atherosclerosis. Nutrients. 2010;2:889–902.22254061 10.3390/nu2080889
72. Ponzo V Goitre I Fadda M Gambino R De Francesco A Soldati L Gentile L Magistroni P Cassader M Bo S Dietary flavonoid intake and cardiovascular risk: a population-based cohort study J Transl Med 2015 13 1 13 10.1186/S12967-015-0573-2/TABLES/4 25591711
Ponzo V, Goitre I, Fadda M, Gambino R, De Francesco A, Soldati L, Gentile L, Magistroni P, Cassader M, Bo S. Dietary flavonoid intake and cardiovascular risk: a population-based cohort study. J Transl Med. 2015;13:1–13. 10.1186/S12967-015-0573-2/TABLES/4.25591711 10.1186/S12967-015-0573-2/TABLES/4
73. McCullough ML Peterson JJ Patel R Jacques PF Shah R Dwyer JT Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults Am J Clin Nutr 2012 95 454 10.3945/AJCN.111.016634 22218162
McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95:454. 10.3945/AJCN.111.016634.22218162 10.3945/AJCN.111.016634
74. Peterson JJ Dwyer JT Jacques PF Mccullough ML Do flavonoids reduce cardiovascular disease incidence or mortality in US and European populations? Nutr Rev 2012 70 491 10.1111/J.1753-4887.2012.00508.X 22946850
Peterson JJ, Dwyer JT, Jacques PF, Mccullough ML. Do flavonoids reduce cardiovascular disease incidence or mortality in US and European populations? Nutr Rev. 2012;70:491. 10.1111/J.1753-4887.2012.00508.X.22946850 10.1111/J.1753-4887.2012.00508.X
75. Hooper L Kroon PA Rimm EB Cohn JS Harvey I Le Cornu KA Ryder JJ Hall WL Cassidy A Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials Am J Clin Nutr 2008 88 38 50 10.1093/AJCN/88.1.38 18614722
Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38–50. 10.1093/AJCN/88.1.38.18614722 10.1093/AJCN/88.1.38
76. Fusi F Trezza A Tramaglino M Sgaragli G Saponara S Spiga O The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channels Pharmacol Res 2020 152 104625 10.1016/J.PHRS.2019.104625 31918018
Fusi F, Trezza A, Tramaglino M, Sgaragli G, Saponara S, Spiga O. The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channels. Pharmacol Res. 2020;152: 104625. 10.1016/J.PHRS.2019.104625.31918018 10.1016/J.PHRS.2019.104625
77. Gross M Flavonoids and cardiovascular disease Pharm Biol 2004 42 21 35 10.3109/13880200490893483
Gross M. Flavonoids and cardiovascular disease. Pharm Biol. 2004;42:21–35. 10.3109/13880200490893483.10.3109/13880200490893483
78. Kozłowska A Szostak-Węgierek D Targeting cardiovascular diseases by flavonols: an update Nutrients 2022 10.3390/nu14071439 36558511
Kozłowska A, Szostak-Węgierek D. Targeting cardiovascular diseases by flavonols: an update. Nutrients. 2022. 10.3390/nu14071439.36558511 10.3390/nu14071439
79. Chen LIJUAN Wu XIAOLI Wang WEIWEI Wang XIA Ma J Quercetin with lycopene modulates enzymic antioxidant genes pathway in isoproterenol cardiotoxicity in rats: cardioprotection by quercetin & lycopene Libyan J Med. 2021 10.1080/19932820.2021.1943924 34151749
Chen LIJUAN, Wu XIAOLI, Wang WEIWEI, Wang XIA, Ma J. Quercetin with lycopene modulates enzymic antioxidant genes pathway in isoproterenol cardiotoxicity in rats: cardioprotection by quercetin & lycopene. Libyan J Med. 2021. 10.1080/19932820.2021.1943924.34151749 10.1080/19932820.2021.1943924
80. Rutkowska M Kolodziejczyk-Czepas J Owczarek A Zakrzewska A Magiera A Olszewska MA Novel insight into biological activity and phytochemical composition of Sorbus Aucuparia L. fruits: fractionated extracts as inhibitors of protein glycation and oxidative/nitrative damage of human plasma components Food Res Int 2021 10.1016/j.foodres.2021.110526 34399504
Rutkowska M, Kolodziejczyk-Czepas J, Owczarek A, Zakrzewska A, Magiera A, Olszewska MA. Novel insight into biological activity and phytochemical composition of Sorbus Aucuparia L. fruits: fractionated extracts as inhibitors of protein glycation and oxidative/nitrative damage of human plasma components. Food Res Int. 2021. 10.1016/j.foodres.2021.110526.34399504 10.1016/j.foodres.2021.110526
81. Ibrahim RYM Saber AA Hammad HBI The possible role of the seaweed ulva fasciata on ameliorating hyperthyroidism-associated heart inflammations in a rat model Environ Sci Pollut Res 2021 10.1007/s11356-020-11036-z
Ibrahim RYM, Saber AA, Hammad HBI. The possible role of the seaweed ulva fasciata on ameliorating hyperthyroidism-associated heart inflammations in a rat model. Environ Sci Pollut Res. 2021. 10.1007/s11356-020-11036-z.10.1007/s11356-020-11036-z
82. Hu J Wang X Cui X Kuang W Li D Wang J Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating MiR-223-3p/FOXO3 Cell Cycle 2021 10.1080/15384101.2021.1932029 34965191
Hu J, Wang X, Cui X, Kuang W, Li D, Wang J. Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating MiR-223-3p/FOXO3. Cell Cycle. 2021. 10.1080/15384101.2021.1932029.34965191 10.1080/15384101.2021.1932029
83. Khan SU Lone AN Khan MS Virani SS Blumenthal RS Nasir K Miller M Michos ED Ballantyne CM Boden WE Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis eClinicalMedicine 2021 10.1016/j.eclinm.2021.100997 34849477
Khan SU, Lone AN, Khan MS, Virani SS, Blumenthal RS, Nasir K, Miller M, Michos ED, Ballantyne CM, Boden WE, et al. Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis. eClinicalMedicine. 2021. 10.1016/j.eclinm.2021.100997.34849477 10.1016/j.eclinm.2021.100997
84. Jain AP Aggarwal KK Zhang P-Y Omega-3 fatty acids and cardiovascular disease Eur Rev Med Pharmacol Sci 2015 19 441 445 25720716
Jain AP, Aggarwal KK, Zhang P-Y. Omega-3 fatty acids and cardiovascular disease. Eur Rev Med Pharmacol Sci. 2015;19:441–5.25720716
85. Yu F Qi S Ji Y Wang X Fang S Cao R Effects of Omega-3 fatty acid on major cardiovascular outcomes: a systematic review and meta-analysis Med (United States) 2022 101 e29556
Yu F, Qi S, Ji Y, Wang X, Fang S, Cao R. Effects of Omega-3 fatty acid on major cardiovascular outcomes: a systematic review and meta-analysis. Med (United States). 2022;101:e29556.
86. Mohebi-Nejad A Bikdeli B Omega-3 supplements and cardiovascular diseases Tanaffos 2014 13 6 25191488
Mohebi-Nejad A, Bikdeli B. Omega-3 supplements and cardiovascular diseases. Tanaffos. 2014;13:6.25191488
87. Chaddha A Eagle KA Omega-3 fatty acids and heart health Circulation 2015 132 e350 e352 10.1161/CIRCULATIONAHA.114.015176 26621655
Chaddha A, Eagle KA. Omega-3 fatty acids and heart health. Circulation. 2015;132:e350–2. 10.1161/CIRCULATIONAHA.114.015176.26621655 10.1161/CIRCULATIONAHA.114.015176
88. Thies F Mills LM Moir S Masson LF Cardiovascular benefits of lycopene: Fantasy or reality? Proc Nutr Soc 2017 76 122 129 10.1017/S0029665116000744 27609297
Thies F, Mills LM, Moir S, Masson LF. Cardiovascular benefits of lycopene: Fantasy or reality? Proc Nutr Soc. 2017;76:122–9.27609297 10.1017/S0029665116000744
89. Zeng J Zhao J Dong B Cai X Jiang J Xue R Yao F Dong Y Liu C Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress J Nutr Biochem 2019 10.1016/j.jnutbio.2019.01.002 31825818
Zeng J, Zhao J, Dong B, Cai X, Jiang J, Xue R, Yao F, Dong Y, Liu C. Lycopene protects against pressure overload-induced cardiac hypertrophy by attenuating oxidative stress. J Nutr Biochem. 2019. 10.1016/j.jnutbio.2019.01.002.31825818 10.1016/j.jnutbio.2019.01.002
90. Xu J Hu H Chen B Yue R Zhou Z Liu Y Zhang S Xu L Wang H Yu Z Lycopene protects against hypoxia/reoxygenation injury by alleviating ER stress induced apoptosis in neonatal mouse cardiomyocytes PLoS ONE 2015 10.1371/journal.pone.0136443 26720758
Xu J, Hu H, Chen B, Yue R, Zhou Z, Liu Y, Zhang S, Xu L, Wang H, Yu Z. Lycopene protects against hypoxia/reoxygenation injury by alleviating ER stress induced apoptosis in neonatal mouse cardiomyocytes. PLoS ONE. 2015. 10.1371/journal.pone.0136443.26720758 10.1371/journal.pone.0136443
91. He Q Zhou W Xiong C Tan G Chen M Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-ΚB Signaling pathway Mol Med Rep 2015 10.3892/mmr.2014.2676 26718267
He Q, Zhou W, Xiong C, Tan G, Chen M. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-ΚB Signaling pathway. Mol Med Rep. 2015. 10.3892/mmr.2014.2676.26718267 10.3892/mmr.2014.2676
92. Palozza P Parrone N Simone RE Catalano A Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies Arch Biochem Biophys 2010 504 26 33 10.1016/j.abb.2010.06.031 20599665
Palozza P, Parrone N, Simone RE, Catalano A. Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys. 2010;504:26–33.20599665 10.1016/j.abb.2010.06.031
93. McEneny J Wade L Young IS Masson L Duthie G McGinty A McMaster C Thies F Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals J Nutr Biochem 2013 10.1016/j.jnutbio.2012.03.015 22819555
McEneny J, Wade L, Young IS, Masson L, Duthie G, McGinty A, McMaster C, Thies F. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J Nutr Biochem. 2013. 10.1016/j.jnutbio.2012.03.015.22819555 10.1016/j.jnutbio.2012.03.015
94. Li YF Chang YY Huang HC Wu YC Yang MD Chao PM Tomato juice supplementation in young women reduces inflammatory adipokine levels independently of body fat reduction Nutrition 2015 10.1016/j.nut.2014.11.008 26837599
Li YF, Chang YY, Huang HC, Wu YC, Yang MD, Chao PM. Tomato juice supplementation in young women reduces inflammatory adipokine levels independently of body fat reduction. Nutrition. 2015. 10.1016/j.nut.2014.11.008.26837599 10.1016/j.nut.2014.11.008
95. Tierney AC Rumble CE Billings LM George ES Effect of dietary and supplemental lycopene on cardiovascular risk factors: a systematic review and meta-analysis Adv Nutr 2020 11 1453 1488 10.1093/advances/nmaa069 32652029
Tierney AC, Rumble CE, Billings LM, George ES. Effect of dietary and supplemental lycopene on cardiovascular risk factors: a systematic review and meta-analysis. Adv Nutr. 2020;11:1453–88.32652029 10.1093/advances/nmaa069
96. Mozos I Stoian D Caraba A Malainer C Horbanczuk JO Atanasov AG Lycopene and vascular health Front Pharmacol 2018 9 521 10.3389/fphar.2018.00521 29875663
Mozos I, Stoian D, Caraba A, Malainer C, Horbanczuk JO, Atanasov AG. Lycopene and vascular health. Front Pharmacol. 2018;9:521.29875663 10.3389/fphar.2018.00521
97. Bin-Jumah MN Nadeem MS Gilani SJ Mubeen B Ullah I Alzarea SI Ghoneim MM Alshehri S Al-Abbasi FA Kazmi I Lycopene: a natural arsenal in the war against oxidative stress and cardiovascular diseases Antioxidants 2022 11 232 10.3390/antiox11020232 35204115
Bin-Jumah MN, Nadeem MS, Gilani SJ, Mubeen B, Ullah I, Alzarea SI, Ghoneim MM, Alshehri S, Al-Abbasi FA, Kazmi I. Lycopene: a natural arsenal in the war against oxidative stress and cardiovascular diseases. Antioxidants. 2022;11:232.35204115 10.3390/antiox11020232
98. Gajendragadkar PR Hubsch A Mäki-Petäjä KM Serg M Wilkinson IB Cheriyan J Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial PLoS ONE 2014 10.1371/journal.pone.0099070 24911964
Gajendragadkar PR, Hubsch A, Mäki-Petäjä KM, Serg M, Wilkinson IB, Cheriyan J. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial. PLoS ONE. 2014. 10.1371/journal.pone.0099070.24911964 10.1371/journal.pone.0099070
99. Costa-Rodrigues J Pinho O Monteiro PRR Can lycopene be considered an effective protection against cardiovascular disease? Food Chem 2018 245 1148 1153 10.1016/j.foodchem.2017.11.055 29287334
Costa-Rodrigues J, Pinho O, Monteiro PRR. Can lycopene be considered an effective protection against cardiovascular disease? Food Chem. 2018;245:1148–53.29287334 10.1016/j.foodchem.2017.11.055
100. de la Monte SM Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for alzheimer’s disease Drugs 2017 77 47 10.1007/S40265-016-0674-0 27988872
de la Monte SM. Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for alzheimer’s disease. Drugs. 2017;77:47. 10.1007/S40265-016-0674-0.27988872 10.1007/S40265-016-0674-0
101. Bathina S Das UN Brain-derived neurotrophic factor and its clinical implications Arch Med Sci 2015 11 1164 10.5114/AOMS.2015.56342 26788077
Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015;11:1164. 10.5114/AOMS.2015.56342.26788077 10.5114/AOMS.2015.56342
102. Bhattacharya T Soares GABE Chopra H Rahman MM Hasan Z Swain SS Cavalu S Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders Mater 2022 15 804 10.3390/MA15030804
Bhattacharya T, Soares GABE, Chopra H, Rahman MM, Hasan Z, Swain SS, Cavalu S. Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Mater. 2022;15:804. 10.3390/MA15030804.10.3390/MA15030804
103. Khan UM Sevindik M Zarrabi A Nami M Ozdemir B Kaplan DN Selamoglu Z Hasan M Kumar M Alshehri MM Lycopene: food sources, biological activities, and human health benefits Oxid Med Cell Longev 2021 2021 2713511 10.1155/2021/2713511 34840666
Khan UM, Sevindik M, Zarrabi A, Nami M, Ozdemir B, Kaplan DN, Selamoglu Z, Hasan M, Kumar M, Alshehri MM, et al. Lycopene: food sources, biological activities, and human health benefits. Oxid Med Cell Longev. 2021;2021:2713511. 10.1155/2021/2713511.34840666 10.1155/2021/2713511
104. Kaur H Chauhan S Sandhir R Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of parkinson’s disease Neurochem Res 2011 10.1007/s11064-011-0469-3 21484267
Kaur H, Chauhan S, Sandhir R. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of parkinson’s disease. Neurochem Res. 2011. 10.1007/s11064-011-0469-3.21484267 10.1007/s11064-011-0469-3
105. Chen D Huang C Chen Z A review for the pharmacological effect of lycopene in central nervous system disorders Biomed Pharmacother 2019 111 791 801 10.1016/j.biopha.2018.12.151 30616078
Chen D, Huang C, Chen Z. A review for the pharmacological effect of lycopene in central nervous system disorders. Biomed Pharmacother. 2019;111:791–801.30616078 10.1016/j.biopha.2018.12.151
106. Paul R Mazumder MK Nath J Deb S Paul S Bhattacharya P Borah A Lycopene - a pleiotropic neuroprotective nutraceutical: deciphering its therapeutic potentials in broad spectrum neurological disorders Neurochem Int 2020 10.1016/j.neuint.2020.104823 32827559
Paul R, Mazumder MK, Nath J, Deb S, Paul S, Bhattacharya P, Borah A. Lycopene - a pleiotropic neuroprotective nutraceutical: deciphering its therapeutic potentials in broad spectrum neurological disorders. Neurochem Int. 2020. 10.1016/j.neuint.2020.104823.32827559 10.1016/j.neuint.2020.104823
107. Hamed M Soliman HAM Eid Z Al Naggar Y Sayed AEDH Dietary feeding lycopene, citric acid, and chlorella alleviated the neurotoxicity of polyethylene microplastics in African catfish (Clarias Gariepinus) Front Environ Sci 2022 10.3389/fenvs.2022.869727
Hamed M, Soliman HAM, Eid Z, Al Naggar Y, Sayed AEDH. Dietary feeding lycopene, citric acid, and chlorella alleviated the neurotoxicity of polyethylene microplastics in African catfish (Clarias Gariepinus). Front Environ Sci. 2022. 10.3389/fenvs.2022.869727.10.3389/fenvs.2022.869727
108. Dong S Zeng Q Mitchell ES Xiu J Duan Y Li C Tiwari JK Hu Y Cao X Zhao Z Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity PLoS ONE 2012 10.1371/journal.pone.0031211 23300631
Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li C, Tiwari JK, Hu Y, Cao X, Zhao Z. Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS ONE. 2012. 10.1371/journal.pone.0031211.23300631 10.1371/journal.pone.0031211
109. So JK Tae GS Hee RP Park M Kim MS Hyung SK Hae YC Mattson MP Lee J Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus J Biol Chem 2008 10.1074/jbc.M708373200
So JK, Tae GS, Hee RP, Park M, Kim MS, Hyung SK, Hae YC, Mattson MP, Lee J. Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem. 2008. 10.1074/jbc.M708373200.10.1074/jbc.M708373200
110. Yu S Wang X He X Wang Y Gao S Ren L Shi Y Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium Ion (MPP+)-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway Cell Stress Chaperones 2016 10.1007/s12192-016-0695-3 27164829
Yu S, Wang X, He X, Wang Y, Gao S, Ren L, Shi Y. Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium Ion (MPP+)-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway. Cell Stress Chaperones. 2016. 10.1007/s12192-016-0695-3.27164829 10.1007/s12192-016-0695-3
111. Mohammadi A Colagar AH Khorshidian A Amini SM The functional roles of curcumin on astrocytes in neurodegenerative diseases NeuroImmunoModulation 2022 29 4 14 10.1159/000517901 34496365
Mohammadi A, Colagar AH, Khorshidian A, Amini SM. The functional roles of curcumin on astrocytes in neurodegenerative diseases. NeuroImmunoModulation. 2022;29:4–14.34496365 10.1159/000517901
112. Nguyen HD Kim MS The protective effects of curcumin on depression: genes, transcription factors, and microRNAs involved J Affect Disord 2022 10.1016/j.jad.2022.09.108 36567155
Nguyen HD, Kim MS. The protective effects of curcumin on depression: genes, transcription factors, and microRNAs involved. J Affect Disord. 2022. 10.1016/j.jad.2022.09.108.36567155 10.1016/j.jad.2022.09.108
113. Ng QX Koh SSH Chan HW Ho CYX Clinical use of curcumin in depression: a meta-analysis J Am Med Dir Assoc 2017 10.1016/j.jamda.2016.12.071 28804010
Ng QX, Koh SSH, Chan HW, Ho CYX. Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc. 2017. 10.1016/j.jamda.2016.12.071.28804010 10.1016/j.jamda.2016.12.071
114. Ashrafi P Jahromy MH potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model Phytomedicine Plus 2022 10.1016/j.phyplu.2022.100334
Ashrafi P, Jahromy MH. potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model. Phytomedicine Plus. 2022. 10.1016/j.phyplu.2022.100334.10.1016/j.phyplu.2022.100334
115. Bishnoi M Chopra K Kulkarni SK Protective effect of curcumin, the active principle of turmeric (Curcuma Longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain Pharmacol Biochem Behav 2008 10.1016/j.pbb.2007.10.009 19138703
Bishnoi M, Chopra K, Kulkarni SK. Protective effect of curcumin, the active principle of turmeric (Curcuma Longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav. 2008. 10.1016/j.pbb.2007.10.009.19138703 10.1016/j.pbb.2007.10.009
116. Asadi S Gholami MS Siassi F Qorbani M Sotoudeh G Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: a randomized, double-blind Placebo-Controlled Clinical Trial Phyther Res 2020 10.1002/ptr.6571
Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: a randomized, double-blind. Placebo-Controlled Clinical Trial Phyther Res. 2020. 10.1002/ptr.6571.10.1002/ptr.6571
117. Salehi B Calina D Docea AO Koirala N Aryal S Lombardo D Pasqua L Taheri Y Castillo CMS Martorell M Curcumin’s nanomedicine formulations for therapeutic application in neurological diseases J Clin Med 2020 9 430 10.3390/jcm9020430 32033365
Salehi B, Calina D, Docea AO, Koirala N, Aryal S, Lombardo D, Pasqua L, Taheri Y, Castillo CMS, Martorell M, et al. Curcumin’s nanomedicine formulations for therapeutic application in neurological diseases. J Clin Med. 2020;9:430.32033365 10.3390/jcm9020430
118. Gagliardi S Morasso C Stivaktakis P Pandini C Tinelli V Tsatsakis A Prosperi D Hickey M Corsi F Cereda C Curcumin formulations and trials: what’s new in neurological diseases Molecules 2020 25 5389 10.3390/molecules25225389 33217959
Gagliardi S, Morasso C, Stivaktakis P, Pandini C, Tinelli V, Tsatsakis A, Prosperi D, Hickey M, Corsi F, Cereda C. Curcumin formulations and trials: what’s new in neurological diseases. Molecules. 2020;25:5389.33217959 10.3390/molecules25225389
119. Mohseni M Sahebkar A Askari G Johnston TP Alikiaii B Bagherniya M The clinical use of curcumin on neurological disorders: an updated systematic review of clinical trials Phyther Res 2021 35 6862 6882 10.1208/s12248012-9444-4
Cheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H., & Baum, L. (2013). Highly stabilized curcumin nanoparticles tested in an in vitro blood–brain barrier model and in Alzheimer's disease Tg2576 mice. The AAPS Journal, 15(2), 324–336. 10.1208/s12248012-9444-410.1208/s12248012-9444-4
120. Garodia P Hegde M Kunnumakkara AB Aggarwal BB Curcumin, inflammation, and neurological disorders: How are they linked? Integr Med Res 2023 12 100968 10.1016/j.imr.2023.100968 37664456
Garodia P, Hegde M, Kunnumakkara AB, Aggarwal BB. Curcumin, inflammation, and neurological disorders: How are they linked? Integr Med Res. 2023;12:100968.37664456 10.1016/j.imr.2023.100968
121. Chopra H Dey PSPS Das D Bhattacharya T Shah M Mubin S Maishu SPSP Akter R Rahman MHMH Karthika C Curcumin nanoparticles as promising therapeutic agents for drug targets Molecules 2021 26 1 28 10.3390/molecules26164998
Chopra H, Dey PSPS, Das D, Bhattacharya T, Shah M, Mubin S, Maishu SPSP, Akter R, Rahman MHMH, Karthika C, et al. Curcumin nanoparticles as promising therapeutic agents for drug targets. Molecules. 2021;26:1–28. 10.3390/molecules26164998.10.3390/molecules26164998
122. Lim GP Chu T Yang F Beech W Frautschy SA Cole GM The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J Neurosci 2001 10.1523/jneurosci.21-21-08370.2001 11606625
Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001. 10.1523/jneurosci.21-21-08370.2001.11606625 10.1523/jneurosci.21-21-08370.2001
123. González-Granillo AE Gnecco D Díaz A Garcés-Ramírez L de la Cruz F Juarez I Morales-Medina JC Flores G Curcumin induces cortico-hippocampal neuronal reshaping and memory improvements in aged mice J Chem Neuroanat 2022 10.1016/j.jchemneu.2022.102091 35334275
González-Granillo AE, Gnecco D, Díaz A, Garcés-Ramírez L, de la Cruz F, Juarez I, Morales-Medina JC, Flores G. Curcumin induces cortico-hippocampal neuronal reshaping and memory improvements in aged mice. J Chem Neuroanat. 2022. 10.1016/j.jchemneu.2022.102091.35334275 10.1016/j.jchemneu.2022.102091
124. Reddy PH Manczak M Yin X Grady MC Mitchell A Tonk S Kuruva CS Bhatti JS Kandimalla R Vijayan M Protective effects of indian spice curcumin against Amyloid-ß in Alzheimer’s disease J Alzheimer’s Dis 2018 61 843 866 10.3233/JAD-170512 29332042
Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, et al. Protective effects of indian spice curcumin against Amyloid-ß in Alzheimer’s disease. J Alzheimer’s Dis. 2018;61:843–66.29332042 10.3233/JAD-170512
125. Yang F Lim GP Begum AN Ubeda OJ Simmons MR Ambegaokar SS Chen P Kayed R Glabe CG Frautschy SA Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 2005 10.1074/jbc.M404751200 16371353
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005. 10.1074/jbc.M404751200.16371353 10.1074/jbc.M404751200
126. Pu Y Zhang H Wang P Zhao Y Li Q Wei X Cui Y Sun J Shang Q Liu D Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway Cell Physiol Biochem 2013 10.1159/000354516 24335167
Pu Y, Zhang H, Wang P, Zhao Y, Li Q, Wei X, Cui Y, Sun J, Shang Q, Liu D, et al. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell Physiol Biochem. 2013. 10.1159/000354516.24335167 10.1159/000354516
127. Qiao P Ma J Wang Y Huang Z Zou Q Cai Z Tang Y Curcumin prevents neuroinflammation by inducing microglia to transform into the M2-phenotype via CaMKKβ-dependent activation of the amp-activated protein kinase signal pathway Curr Alzheimer Res 2020 10.2174/1567205017666201111120919 33176649
Qiao P, Ma J, Wang Y, Huang Z, Zou Q, Cai Z, Tang Y. Curcumin prevents neuroinflammation by inducing microglia to transform into the M2-phenotype via CaMKKβ-dependent activation of the amp-activated protein kinase signal pathway. Curr Alzheimer Res. 2020. 10.2174/1567205017666201111120919.33176649 10.2174/1567205017666201111120919
128. Shao S Ye X Su W Wang Y Curcumin alleviates alzheimer’s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway J Chem Neuroanat 2023 134 102363 10.1016/j.jchemneu.2023.102363 37989445
Shao S, Ye X, Su W, Wang Y. Curcumin alleviates alzheimer’s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway. J Chem Neuroanat. 2023;134: 102363. 10.1016/j.jchemneu.2023.102363.37989445 10.1016/j.jchemneu.2023.102363
129. Hassan FU Rehman MSU Khan MS Ali MA Javed A Nawaz A Yang C Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects Front Genet 2019 10.3389/fgene.2019.00514 31214247
Hassan FU, Rehman MSU, Khan MS, Ali MA, Javed A, Nawaz A, Yang C. Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front Genet. 2019. 10.3389/fgene.2019.00514.31214247 10.3389/fgene.2019.00514
130. Abdul-Rahman T Awuah WA Mikhailova T Kalmanovich J Mehta A Ng JC Coghlan MA Zivcevska M Tedeschi AJ de Oliveira EC Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer’s disease BioFactors 2024 10.1002/biof.2039 38226733
Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi AJ, de Oliveira EC, et al. Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer’s disease. BioFactors. 2024. 10.1002/biof.2039.38226733 10.1002/biof.2039
131. Khayatan D Razavi SM Arab ZN Niknejad AH Nouri K Momtaz S Gumpricht E Jamialahmadi T Abdolghaffari AH Barreto GE Protective effects of curcumin against traumatic brain injury Biomed Pharmacother 2022 154 113621 10.1016/j.biopha.2022.113621 36055110
Khayatan D, Razavi SM, Arab ZN, Niknejad AH, Nouri K, Momtaz S, Gumpricht E, Jamialahmadi T, Abdolghaffari AH, Barreto GE, et al. Protective effects of curcumin against traumatic brain injury. Biomed Pharmacother. 2022;154:113621.36055110 10.1016/j.biopha.2022.113621
132. Kabir ER Chowdhury NM Yasmin H Kabir MT Akter R Perveen A Ashraf GM Akter S Rahman MH Sweilam SH Unveiling the potential of polyphenols as anti-amyloid molecules in Alzheimer’s disease Curr Neuropharmacol 2023 21 787 807 10.2174/1570159X20666221010113812 36221865
Kabir ER, Chowdhury NM, Yasmin H, Kabir MT, Akter R, Perveen A, Ashraf GM, Akter S, Rahman MH, Sweilam SH. Unveiling the potential of polyphenols as anti-amyloid molecules in Alzheimer’s disease. Curr Neuropharmacol. 2023;21:787–807. 10.2174/1570159X20666221010113812.36221865 10.2174/1570159X20666221010113812
133. Gautam S Karmakar S Batra R Sharma P Pradhan P Singh J Kundu B Chowdhury PK Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative Biochim Biophys Acta - Proteins Proteomics 2017 1865 589 603 10.1016/J.BBAPAP.2017.02.014 28238838
Gautam S, Karmakar S, Batra R, Sharma P, Pradhan P, Singh J, Kundu B, Chowdhury PK. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative. Biochim Biophys Acta - Proteins Proteomics. 2017;1865:589–603. 10.1016/J.BBAPAP.2017.02.014.28238838 10.1016/J.BBAPAP.2017.02.014
134. Arbizu-Berrocal SH Kim H Fang C Krenek KA Talcott ST Mertens-Talcott SU Polyphenols from mango (Mangifera Indica L.) modulate PI3K/AKT/MTOR-associated micro-RNAs and reduce inflammation in non-cancer and induce cell death in breast cancer cells J Funct Foods 2019 55 9 16 10.1016/J.JFF.2019.01.035
Arbizu-Berrocal SH, Kim H, Fang C, Krenek KA, Talcott ST, Mertens-Talcott SU. Polyphenols from mango (Mangifera Indica L.) modulate PI3K/AKT/MTOR-associated micro-RNAs and reduce inflammation in non-cancer and induce cell death in breast cancer cells. J Funct Foods. 2019;55:9–16. 10.1016/J.JFF.2019.01.035.10.1016/J.JFF.2019.01.035
135. Jiang H Shang X Wu H Gautam SC Al-Holou S Li C Kuo J Zhang L Chopp M Resveratrol downregulates PI3K/Akt/MTOR signaling pathways in human U251 glioma cells J Exp Ther Oncol 2009 8 25 33 19827268
Jiang H, Shang X, Wu H, Gautam SC, Al-Holou S, Li C, Kuo J, Zhang L, Chopp M. Resveratrol downregulates PI3K/Akt/MTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol. 2009;8:25–33.19827268
136. Anjum J Mitra S Das R Alam R Mojumder A Emran TB Khan H A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics Pharmacol Res 2022 184 106398 10.1016/J.PHRS.2022.106398 35988867
Anjum J, Mitra S, Das R, Alam R, Mojumder A, Emran TB, Khan H. A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics. Pharmacol Res. 2022;184:106398. 10.1016/J.PHRS.2022.106398.35988867 10.1016/J.PHRS.2022.106398
137. Islam F Roy S Zehravi M Paul S Sutradhar H Yaidikar L Kumar BR Dogiparthi LK Prema S Nainu F Polyphenols targeting MAP kinase signaling pathway in neurological diseases: understanding molecular mechanisms and therapeutic targets Mol Neurobiol 2023 10.1007/S12035-023-03706-Z 37922063
Islam F, Roy S, Zehravi M, Paul S, Sutradhar H, Yaidikar L, Kumar BR, Dogiparthi LK, Prema S, Nainu F, et al. Polyphenols targeting MAP kinase signaling pathway in neurological diseases: understanding molecular mechanisms and therapeutic targets. Mol Neurobiol. 2023. 10.1007/S12035-023-03706-Z.37922063 10.1007/S12035-023-03706-Z
138. Pacifici F Salimei C Pastore D Malatesta G Ricordi C Donadel G Bellia A Rovella V Tafani M Garaci E The protective effect of a unique mix of polyphenols and micronutrients against neurodegeneration induced by an in vitro model of parkinson’s disease Int J Mol Sci 2022 23 3110 10.3390/ijms23063110 35328530
Pacifici F, Salimei C, Pastore D, Malatesta G, Ricordi C, Donadel G, Bellia A, Rovella V, Tafani M, Garaci E, et al. The protective effect of a unique mix of polyphenols and micronutrients against neurodegeneration induced by an in vitro model of parkinson’s disease. Int J Mol Sci. 2022;23:3110.35328530 10.3390/ijms23063110
139. Hole KL Williams RJ Flavonoids as an intervention for Alzheimer’s disease: progress and hurdles towards defining a mechanism of action1 Brain Plast 2020 10.3233/bpl-200098
Hole KL, Williams RJ. Flavonoids as an intervention for Alzheimer’s disease: progress and hurdles towards defining a mechanism of action1. Brain Plast. 2020. 10.3233/bpl-200098.10.3233/bpl-200098
140. Hole KL Williams RJ Flavonoids as an intervention for Alzheimer’s disease: progress and hurdles towards defining a mechanism of action Brain Plast 2021 6 167 192 10.3233/BPL-200098 33782649
Hole KL, Williams RJ. Flavonoids as an intervention for Alzheimer’s disease: progress and hurdles towards defining a mechanism of action. Brain Plast. 2021;6:167–92. 10.3233/BPL-200098.33782649 10.3233/BPL-200098
141. Gao X Cassidy A Schwarzschild MA Rimm EB Ascherio A Habitual intake of dietary flavonoids and risk of parkinson disease Neurology 2012 78 1138 1145 10.1212/WNL.0b013e31824f7fc4 22491871
Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of parkinson disease. Neurology. 2012;78:1138–45. 10.1212/WNL.0b013e31824f7fc4.22491871 10.1212/WNL.0b013e31824f7fc4
142. Dinda B Dinda M Roy A Dinda S Dietary plant flavonoids in prevention of obesity and diabetes Adv Protein Chem Struct Biol 2020 10.1016/bs.apcsb.2019.08.006 32085882
Dinda B, Dinda M, Roy A, Dinda S. Dietary plant flavonoids in prevention of obesity and diabetes. Adv Protein Chem Struct Biol. 2020. 10.1016/bs.apcsb.2019.08.006.32085882 10.1016/bs.apcsb.2019.08.006
143. Zhou M Konigsberg WH Hao C Pan Y Sun J Wang X Bioactivity and mechanisms of flavonoids in decreasing insulin resistance J Enzyme Inhib Med Chem 2023 38 2199168 10.1080/14756366.2023.2199168 37036026
Zhou M, Konigsberg WH, Hao C, Pan Y, Sun J, Wang X. Bioactivity and mechanisms of flavonoids in decreasing insulin resistance. J Enzyme Inhib Med Chem. 2023;38:2199168.37036026 10.1080/14756366.2023.2199168
144. He C Liu X Jiang Z Geng S Ma H Liu B 2019 Interaction mechanism of flavonoids and α-glucosidase: experimental and molecular modelling studies Foods 10.3390/foods8090355
He C, Liu X, Jiang Z, Geng S, Ma H, Liu B. Interaction mechanism of flavonoids and α-glucosidase: experimental and molecular modelling studies. 2019. Foods. 10.3390/foods8090355.10.3390/foods8090355
145. Barber E Houghton MJ Williamson G 2021 Flavonoids as human intestinal α-glucosidase inhibitors Foods 10.3390/foods10081939
Barber E, Houghton MJ, Williamson G. Flavonoids as human intestinal α-glucosidase inhibitors. 2021. Foods. 10.3390/foods10081939.10.3390/foods10081939
146. Takahama U Hirota S Interactions of flavonoids with α-amylase and starch slowing down its digestion Food Funct 2018 9 677 687 10.1039/C7FO01539A 29292445
Takahama U, Hirota S. Interactions of flavonoids with α-amylase and starch slowing down its digestion. Food Funct. 2018;9:677–87.29292445 10.1039/C7FO01539A
147. Ahn S Jun S Joung H Association of total flavonoid intake with hypo- HDL-cholesterolemia among korean adults: effect modification by polyunsaturated fatty acid intake Nutrients 2020 10.3390/nu12010195 33139592
Ahn S, Jun S, Joung H. Association of total flavonoid intake with hypo- HDL-cholesterolemia among korean adults: effect modification by polyunsaturated fatty acid intake. Nutrients. 2020. 10.3390/nu12010195.33139592 10.3390/nu12010195
148. Bao L Hu L Zhang Y Wang Y Hypolipidemic effects of flavonoids extracted from lomatogonium rotatum Exp Ther Med 2016 10.3892/etm.2016.3038 28123499
Bao L, Hu L, Zhang Y, Wang Y. Hypolipidemic effects of flavonoids extracted from lomatogonium rotatum. Exp Ther Med. 2016. 10.3892/etm.2016.3038.28123499 10.3892/etm.2016.3038
149. Khalilpourfarshbafi M Gholami K Murugan DD Abdul Sattar MZ Abdullah NA Differential effects of dietary flavonoids on adipogenesis Eur J Nutr 2019 58 5 25 10.1007/s00394-018-1663-8 29541908
Khalilpourfarshbafi M, Gholami K, Murugan DD, Abdul Sattar MZ, Abdullah NA. Differential effects of dietary flavonoids on adipogenesis. Eur J Nutr. 2019;58:5–25.29541908 10.1007/s00394-018-1663-8
150. Zhang X Li X Fang H Guo F Li F Chen A Huang S Flavonoids as inducers of white adipose tissue browning and thermogenesis: signalling pathways and molecular triggers Nutr Metab 2019 16 1 15 10.1186/s12986-019-0370-7
Zhang X, Li X, Fang H, Guo F, Li F, Chen A, Huang S. Flavonoids as inducers of white adipose tissue browning and thermogenesis: signalling pathways and molecular triggers. Nutr Metab. 2019;16:1–15.10.1186/s12986-019-0370-7
151. Kang HW Lee SG Otieno D Ha K Flavonoids, potential bioactive compounds, and non-shivering thermogenesis Nutrients 2018 10 1168 10.3390/nu10091168 30149637
Kang HW, Lee SG, Otieno D, Ha K. Flavonoids, potential bioactive compounds, and non-shivering thermogenesis. Nutrients. 2018;10:1168.30149637 10.3390/nu10091168
152. Zhao X An X Yang C Sun W Ji H Lian F The crucial role and mechanism of insulin resistance in metabolic disease Front Endocrinol (Lausanne) 2023 14 1149239 10.3389/fendo.2023.1149239 37056675
Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). 2023;14:1149239.37056675 10.3389/fendo.2023.1149239
153. Sung CC Liao MT Lu KC Wu CC Role of vitamin D in insulin resistance J Biomed Biotechnol 2012 2012 634195 10.1155/2012/634195 22988423
Sung CC, Liao MT, Lu KC, Wu CC. Role of vitamin D in insulin resistance. J Biomed Biotechnol. 2012;2012: 634195.22988423 10.1155/2012/634195
154. Ashraf A Alvarez JA Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis Int J Endocrinol 2010 2010 351385 20011094
Ashraf A, Alvarez JA. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010: 351385.20011094
155. Pittas AG Jorde R Kawahara T Dawson-Hughes B Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab 2020 105 3721 3733 10.1210/clinem/dgaa594 32844212
Pittas AG, Jorde R, Kawahara T, Dawson-Hughes B. Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab. 2020;105:3721–33.32844212 10.1210/clinem/dgaa594
156. Jain AB Jain VA Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications J Clin Diagnostic Res 2012 10.7860/JCDR/2012/4791.2625
Jain AB, Jain VA. Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications. J Clin Diagnostic Res. 2012. 10.7860/JCDR/2012/4791.2625.10.7860/JCDR/2012/4791.2625
157. Tobias DK Luttmann-Gibson H Mora S Danik J Bubes V Copeland T LeBoff MS Cook NR Lee IM Buring JE Association of body weight with response to vitamin D supplementation and metabolism JAMA Netw open 2023 10.1001/jamanetworkopen.2022.50681 36648947
Tobias DK, Luttmann-Gibson H, Mora S, Danik J, Bubes V, Copeland T, LeBoff MS, Cook NR, Lee IM, Buring JE, et al. Association of body weight with response to vitamin D supplementation and metabolism. JAMA Netw open. 2023. 10.1001/jamanetworkopen.2022.50681.36648947 10.1001/jamanetworkopen.2022.50681
158. Manna P Jain SK Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies Metab Syndr Relat Disord 2015 13 423 444 10.1089/met.2015.0095 26569333
Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423–44.26569333 10.1089/met.2015.0095
159. Alcalá M Sánchez-Vera I Sevillano J Herrero L Serra D Ramos MP Viana M Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity Obesity 2015 10.1002/oby.21135 26148343
Alcalá M, Sánchez-Vera I, Sevillano J, Herrero L, Serra D, Ramos MP, Viana M. Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity. 2015. 10.1002/oby.21135.26148343 10.1002/oby.21135
160. Zhang Q Guo M Chen T Cheng H Yang Q Zhao Z She R Yang X Xiao W Yang X Walking and taking vitamin C alleviates oxidative stress and inflammation in overweight students, even in the short-term Front Public Heal 2022 10.3389/fpubh.2022.1024864
Zhang Q, Guo M, Chen T, Cheng H, Yang Q, Zhao Z, She R, Yang X, Xiao W, Yang X, et al. Walking and taking vitamin C alleviates oxidative stress and inflammation in overweight students, even in the short-term. Front Public Heal. 2022. 10.3389/fpubh.2022.1024864.10.3389/fpubh.2022.1024864
161. Hanhineva K Törrönen R Bondia-Pons I Pekkinen J Kolehmainen M Mykkänen H Poutanen K Impact of dietary polyphenols on carbohydrate metabolism Int J Mol Sci 2010 11 1365 1402 10.3390/ijms11041365 20480025
Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, Poutanen K. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci. 2010;11:1365–402.20480025 10.3390/ijms11041365
162. de Paulo Farias D de Araújo FF Neri-Numa IA Pastore GM Antidiabetic potential of dietary polyphenols: a mechanistic review Food Res Int 2021 145 110383 10.1016/j.foodres.2021.110383 34112386
de Paulo Farias D, de Araújo FF, Neri-Numa IA, Pastore GM. Antidiabetic potential of dietary polyphenols: a mechanistic review. Food Res Int. 2021;145:110383.34112386 10.1016/j.foodres.2021.110383
163. Nie T Cooper GJS Mechanisms underlying the antidiabetic activities of polyphenolic compounds: a review Front Pharmacol 2021 12 798329 10.3389/fphar.2021.798329 34970150
Nie T, Cooper GJS. Mechanisms underlying the antidiabetic activities of polyphenolic compounds: a review. Front Pharmacol. 2021;12:798329.34970150 10.3389/fphar.2021.798329
164. Krawczyk M Burzynska-Pedziwiatr I Wozniak LA Bukowiecka-Matusiak M Impact of polyphenols on inflammatory and oxidative stress factors in diabetes mellitus: nutritional antioxidants and their application in improving antidiabetic therapy Biomolecules 2023 13 1402 10.3390/biom13091402 37759802
Krawczyk M, Burzynska-Pedziwiatr I, Wozniak LA, Bukowiecka-Matusiak M. Impact of polyphenols on inflammatory and oxidative stress factors in diabetes mellitus: nutritional antioxidants and their application in improving antidiabetic therapy. Biomolecules. 2023;13:1402.37759802 10.3390/biom13091402
165. Ćorković I Gašo-Sokač D Pichler A Šimunović J Kopjar M Dietary polyphenols as natural inhibitors of α-Amylase and α-Glucosidase Life 2022 12 1692 10.3390/life12111692 36362847
Ćorković I, Gašo-Sokač D, Pichler A, Šimunović J, Kopjar M. Dietary polyphenols as natural inhibitors of α-Amylase and α-Glucosidase. Life. 2022;12:1692.36362847 10.3390/life12111692
166. Riyaphan J Pham DC Leong MK Weng CF In silico approaches to identify polyphenol compounds as α-Glucosidase and α-Amylase inhibitors against type-ii diabetes Biomolecules 1877 2021 11
Riyaphan J, Pham DC, Leong MK, Weng CF. In silico approaches to identify polyphenol compounds as α-Glucosidase and α-Amylase inhibitors against type-ii diabetes. Biomolecules. 1877;2021:11.
167. McArdle MA Finucane OM Connaughton RM McMorrow AM Roche HM Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies Front Endocrinol (Lausanne) 2013 4 52 10.3389/fendo.2013.00052 23675368
McArdle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.23675368 10.3389/fendo.2013.00052
168. Niewiadomska J Gajek-Marecka A Gajek J Noszczyk-Nowak A Biological potential of polyphenols in the context of metabolic syndrome: an analysis of studies on animal models Biology (Basel) 2022 11 559 35453758
Niewiadomska J, Gajek-Marecka A, Gajek J, Noszczyk-Nowak A. Biological potential of polyphenols in the context of metabolic syndrome: an analysis of studies on animal models. Biology (Basel). 2022;11:559.35453758
169. Wang S Moustaid-Moussa N Chen L Mo H Shastri A Su R Bapat P Kwun IS Shen CL Novel insights of dietary polyphenols and obesity J Nutr Biochem 2014 25 1 18 10.1016/j.jnutbio.2013.09.001 24314860
Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun IS, Shen CL. Novel insights of dietary polyphenols and obesity. J Nutr Biochem. 2014;25:1–18.24314860 10.1016/j.jnutbio.2013.09.001
170. Singh M Thrimawithana T Shukla R Adhikari B Managing obesity through natural polyphenols: a review Futur Foods 2020 1 100002 10.1016/j.fufo.2020.100002
Singh M, Thrimawithana T, Shukla R, Adhikari B. Managing obesity through natural polyphenols: a review. Futur Foods. 2020;1:100002.10.1016/j.fufo.2020.100002
171. Corrêa TAF Rogero MM Hassimotto NMA Lajolo FM The two-way polyphenols-microbiota interactions and their effects on obesity and related metabolic diseases Front Nutr 2019 6 188 10.3389/fnut.2019.00188 31921881
Corrêa TAF, Rogero MM, Hassimotto NMA, Lajolo FM. The two-way polyphenols-microbiota interactions and their effects on obesity and related metabolic diseases. Front Nutr. 2019;6:188.31921881 10.3389/fnut.2019.00188
172. Ma G Chen Y Polyphenol supplementation benefits human health via gut microbiota: a systematic review via meta-analysis J Funct Foods 2020 66 103829 10.1016/j.jff.2020.103829
Ma G, Chen Y. Polyphenol supplementation benefits human health via gut microbiota: a systematic review via meta-analysis. J Funct Foods. 2020;66:103829.10.1016/j.jff.2020.103829
173. Catalkaya G Venema K Lucini L Rocchetti G Delmas D Daglia M De Filippis A Xiao H Quiles JL Xiao J Interaction of dietary polyphenols and gut microbiota: microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health Food Front 2020 1 109 133 10.1002/fft2.25
Catalkaya G, Venema K, Lucini L, Rocchetti G, Delmas D, Daglia M, De Filippis A, Xiao H, Quiles JL, Xiao J, et al. Interaction of dietary polyphenols and gut microbiota: microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health. Food Front. 2020;1:109–33.10.1002/fft2.25
174. Li J Wu N Chen X Chen H Yang X Liu C curcumin protects islet cells from glucolipotoxicity by inhibiting oxidative stress and NADPH oxidase activity both in vitro and in vivo Islets 2019 10.1080/19382014.2019.1690944 31750757
Li J, Wu N, Chen X, Chen H, Yang X, Liu C. curcumin protects islet cells from glucolipotoxicity by inhibiting oxidative stress and NADPH oxidase activity both in vitro and in vivo. Islets. 2019. 10.1080/19382014.2019.1690944.31750757 10.1080/19382014.2019.1690944
175. Hussain Y Khan H Alotaibi G Khan F Alam W Aschner M Jeandet P Saso L How curcumin targets inflammatory mediators in diabetes: therapeutic insights and possible solutions Molecules 2022 10.3390/molecules27134058 36615218
Hussain Y, Khan H, Alotaibi G, Khan F, Alam W, Aschner M, Jeandet P, Saso L. How curcumin targets inflammatory mediators in diabetes: therapeutic insights and possible solutions. Molecules. 2022. 10.3390/molecules27134058.36615218 10.3390/molecules27134058
176. Metawea MR Abdelrazek HMA El-Hak HNG Moghazee MM Marie OM Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male sprague-dawley rats Environ Sci Pollut Res 2023 10.1007/s11356-023-26260-6
Metawea MR, Abdelrazek HMA, El-Hak HNG, Moghazee MM, Marie OM. Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male sprague-dawley rats. Environ Sci Pollut Res. 2023. 10.1007/s11356-023-26260-6.10.1007/s11356-023-26260-6
177. Abdul-Hamid M Moustafa N Protective effect of curcumin on histopathology and ultrastructure of pancreas in the alloxan treated rats for induction of diabetes J Basic Appl Zool 2013 10.1016/j.jobaz.2013.07.003
Abdul-Hamid M, Moustafa N. Protective effect of curcumin on histopathology and ultrastructure of pancreas in the alloxan treated rats for induction of diabetes. J Basic Appl Zool. 2013. 10.1016/j.jobaz.2013.07.003.10.1016/j.jobaz.2013.07.003
178. Den Hartogh DJ Gabriel A Tsiani E Antidiabetic properties of curcumin ii: evidence from in vivo studies Nutrients 2020 12 58 10.3390/nu12010058
Den Hartogh DJ, Gabriel A, Tsiani E. Antidiabetic properties of curcumin ii: evidence from in vivo studies. Nutrients. 2020;12:58.10.3390/nu12010058
179. Kasprzak-Drozd K Oniszczuk T Gancarz M Kondracka A Rusinek R Oniszczuk A Curcumin and weight loss: Does it work? Int J Mol Sci 2022 23 639 10.3390/ijms23020639 35054828
Kasprzak-Drozd K, Oniszczuk T, Gancarz M, Kondracka A, Rusinek R, Oniszczuk A. Curcumin and weight loss: Does it work? Int J Mol Sci. 2022;23:639.35054828 10.3390/ijms23020639
180. Xie XY Kong PR Wu JF Li Y Li YX Curcumin attenuates lipolysis stimulated by tumor necrosis factor-α or isoproterenol in 3T3-L1 adipocytes Phytomedicine 2012 10.1016/j.phymed.2012.09.003 23141427
Xie XY, Kong PR, Wu JF, Li Y, Li YX. Curcumin attenuates lipolysis stimulated by tumor necrosis factor-α or isoproterenol in 3T3-L1 adipocytes. Phytomedicine. 2012. 10.1016/j.phymed.2012.09.003.23141427 10.1016/j.phymed.2012.09.003
181. Pan Y Zhao D Yu N An T Miao J Mo F Gu Y Zhang D Gao S Jiang G Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signalling pathway in high-fat diet-induced obese mice and 3t3-L1 adipocytes R Soc Open Sci 2017 10.1098/rsos.170917 29308264
Pan Y, Zhao D, Yu N, An T, Miao J, Mo F, Gu Y, Zhang D, Gao S, Jiang G. Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signalling pathway in high-fat diet-induced obese mice and 3t3-L1 adipocytes. R Soc Open Sci. 2017. 10.1098/rsos.170917.29308264 10.1098/rsos.170917
182. Zhang DW Fu M Gao SH Liu JL Curcumin and diabetes: a systematic review evidence-based complement Altern Med 2013 2013 636053 10.1155/2013/636053
Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review evidence-based complement. Altern Med. 2013;2013: 636053. 10.1155/2013/636053.10.1155/2013/636053
183. Ghorbani Z Hekmatdoost A Mirmiran P Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin Int J Endocrinol Metab 2014 12 18081 10.5812/IJEM.18081
Ghorbani Z, Hekmatdoost A, Mirmiran P. Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab. 2014;12:18081. 10.5812/IJEM.18081.10.5812/IJEM.18081
184. Zhong Y Xiao Y Gao J Zheng Z Zhang Z Yao L Li D Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota Nutr Metab 2022 10.1186/s12986-022-00712-1
Zhong Y, Xiao Y, Gao J, Zheng Z, Zhang Z, Yao L, Li D. Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota. Nutr Metab. 2022. 10.1186/s12986-022-00712-1.10.1186/s12986-022-00712-1
185. Eidi A Eidi M Esmaeili E Antidiabetic effect of garlic (Allium Sativum L.) in normal and streptozotocin-induced diabetic rats Phytomedicine 2006 10.1016/j.phymed.2005.09.010 17085291
Eidi A, Eidi M, Esmaeili E. Antidiabetic effect of garlic (Allium Sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine. 2006. 10.1016/j.phymed.2005.09.010.17085291 10.1016/j.phymed.2005.09.010
186. Thomson M Al-Amin ZM Al-Qattan KK Shaban LH Ali M Anti-diabetic and hypolipidaemic properties of garlic (Allium Sativum) in streptozotocin-induced diabetic rats Int J Diabetes Metab 2019 10.1159/000497643
Thomson M, Al-Amin ZM, Al-Qattan KK, Shaban LH, Ali M. Anti-diabetic and hypolipidaemic properties of garlic (Allium Sativum) in streptozotocin-induced diabetic rats. Int J Diabetes Metab. 2019. 10.1159/000497643.10.1159/000497643
187. Ansary J Forbes-Hernández TY Gil E Cianciosi D Zhang J Elexpuru-Zabaleta M Simal-Gandara J Giampieri F Battino M Potential health benefit of garlic based on human intervention studies: a brief overview Antioxidants 2020 9 619 10.3390/antiox9070619 32679751
Ansary J, Forbes-Hernández TY, Gil E, Cianciosi D, Zhang J, Elexpuru-Zabaleta M, Simal-Gandara J, Giampieri F, Battino M. Potential health benefit of garlic based on human intervention studies: a brief overview. Antioxidants. 2020;9:619.32679751 10.3390/antiox9070619
188. Ribeiro M Alvarenga L Cardozo LF Chermut TR Sequeira J Moreira LDSG Mafra D From the distinctive smell to therapeutic effects: garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease Clin Nutr 2021 40 4807 4819 10.1016/j.clnu.2021.03.005 34147285
Ribeiro M, Alvarenga L, Cardozo LF, Chermut TR, Sequeira J, Moreira LDSG, Mafra D. From the distinctive smell to therapeutic effects: garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease. Clin Nutr. 2021;40:4807–19.34147285 10.1016/j.clnu.2021.03.005
189. Liu CT Hse H Lii CK Chen PS Sheen LY Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats Eur J Pharmacol 2005 10.1016/j.ejphar.2005.04.031 16386244
Liu CT, Hse H, Lii CK, Chen PS, Sheen LY. Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats. Eur J Pharmacol. 2005. 10.1016/j.ejphar.2005.04.031.16386244 10.1016/j.ejphar.2005.04.031
190. Wang J Zhang X Lan H Wang W Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): a meta-analysis of randomized controlled trials Food Nutr Res 2017 10.1080/16546628.2017.1377571 29056892
Wang J, Zhang X, Lan H, Wang W. Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): a meta-analysis of randomized controlled trials. Food Nutr Res. 2017. 10.1080/16546628.2017.1377571.29056892 10.1080/16546628.2017.1377571
191. Sadeghi M Moradi M Madanchi H Johari B In silico study of garlic (Allium Sativum L.)-derived compounds molecular interactions with α-Glucosidase Silico Pharmacol. 2021 10.1007/s40203-020-00072-9
Sadeghi M, Moradi M, Madanchi H, Johari B. In silico study of garlic (Allium Sativum L.)-derived compounds molecular interactions with α-Glucosidase. Silico Pharmacol. 2021. 10.1007/s40203-020-00072-9.10.1007/s40203-020-00072-9
192. Wu J Wang Y Li S Wu T Liu R Sui W Zhang M Black garlic melanoidins inhibit in vitro α-amylase and α-glucosidase activity: the role of high-molecular-weight fluorescent compounds J Sci Food Agric 2023 10.1002/jsfa.12634 38087418
Wu J, Wang Y, Li S, Wu T, Liu R, Sui W, Zhang M. Black garlic melanoidins inhibit in vitro α-amylase and α-glucosidase activity: the role of high-molecular-weight fluorescent compounds. J Sci Food Agric. 2023. 10.1002/jsfa.12634.38087418 10.1002/jsfa.12634
193. Gadidala SK Johny E Thomas C Nadella M Undela K Adela R Effect of garlic extract on markers of lipid metabolism and inflammation in coronary artery disease (CAD) Patients: A systematic review and meta-analysis Phyther Res 2023 10.1002/ptr.7729
Gadidala SK, Johny E, Thomas C, Nadella M, Undela K, Adela R. Effect of garlic extract on markers of lipid metabolism and inflammation in coronary artery disease (CAD) Patients: A systematic review and meta-analysis. Phyther Res. 2023. 10.1002/ptr.7729.10.1002/ptr.7729
194. Chen K Nakasone Y Yi S Ibrahim HR Sakao K Hossain MA Hou DX Natural garlic organosulfur compounds prevent metabolic disorder of lipid and glucose by increasing gut commensal bacteroides acidifaciens J Agric Food Chem 2022 10.1021/acs.jafc.2c00555 36584355
Chen K, Nakasone Y, Yi S, Ibrahim HR, Sakao K, Hossain MA, Hou DX. Natural garlic organosulfur compounds prevent metabolic disorder of lipid and glucose by increasing gut commensal bacteroides acidifaciens. J Agric Food Chem. 2022. 10.1021/acs.jafc.2c00555.36584355 10.1021/acs.jafc.2c00555
195. Warshafsky S Kamer RS Sivak SL Effect of garlic on total serum cholesterol: a meta-analysis Ann Intern Med 1993 119 599 605 10.7326/0003-4819-119-7_Part_1-199310010-00009 8363171
Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med. 1993;119:599–605.8363171 10.7326/0003-4819-119-7_Part_1-199310010-00009
196. Zupančič D Korać-Prlić J Kreft ME Franković L Vilović K Jeruc J Romih R Terzić J Vitamin A rich diet diminishes early urothelial carcinogenesis by altering retinoic acid signaling Cancers (Basel) 2020 10.3390/cancers12071712 32605249
Zupančič D, Korać-Prlić J, Kreft ME, Franković L, Vilović K, Jeruc J, Romih R, Terzić J. Vitamin A rich diet diminishes early urothelial carcinogenesis by altering retinoic acid signaling. Cancers (Basel). 2020. 10.3390/cancers12071712.32605249 10.3390/cancers12071712
197. Tang JE Wang RJ Zhong H Yu B Chen Y Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies World J Surg Oncol. 2014 10.1186/1477-7819-12-130 25547003
Tang JE, Wang RJ, Zhong H, Yu B, Chen Y. Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies. World J Surg Oncol. 2014. 10.1186/1477-7819-12-130.25547003 10.1186/1477-7819-12-130
198. Magrì A Germano G Lorenzato A Lamba S Chilà R Montone M Amodio V Ceruti T Sassi F Arena S High-dose vitamin C enhances cancer immunotherapy Sci Transl Med 2020 10.1126/scitranslmed.aay8707 32102933
Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, et al. High-dose vitamin C enhances cancer immunotherapy. Sci Transl Med. 2020. 10.1126/scitranslmed.aay8707.32102933 10.1126/scitranslmed.aay8707
199. Böttger F Vallés-Martí A Cahn L Jimenez CR High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer J Exp Clin Cancer Res 2021 40 1 44 10.1186/s13046-021-02134-y 33390177
Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res. 2021;40:1–44.33390177 10.1186/s13046-021-02134-y
200. Mussa A Mohd Idris RA Ahmed N Ahmad S Murtadha AH Tengku Din TADAA Hassan R High-dose vitamin C for cancer therapy Pharmaceuticals 2022 15 711 10.3390/ph15060711 35745630
Mussa A, Mohd Idris RA, Ahmed N, Ahmad S, Murtadha AH, Tengku Din TADAA, Hassan R. High-dose vitamin C for cancer therapy. Pharmaceuticals. 2022;15:711.35745630 10.3390/ph15060711
201. Satheesh NJ Samuel SM Büsselberg D Combination therapy with vitamin C could eradicate cancer stem cells Biomolecules 2020 10 79 10.3390/biom10010079 31947879
Satheesh NJ, Samuel SM, Büsselberg D. Combination therapy with vitamin C could eradicate cancer stem cells. Biomolecules. 2020;10:79.31947879 10.3390/biom10010079
202. Zasowska-Nowak A Nowak PJ Ciałkowska-Rysz A High-dose vitamin C in advanced-stage cancer patients Nutrients 2021 13 735 10.3390/nu13030735 33652579
Zasowska-Nowak A, Nowak PJ, Ciałkowska-Rysz A. High-dose vitamin C in advanced-stage cancer patients. Nutrients. 2021;13:735.33652579 10.3390/nu13030735
203. Abiri B Vafa M Vitamin C and cancer: the role of vitamin C in disease progression and quality of life in cancer patients Nutr Cancer 2021 10.1080/01635581.2020.1795692 32691657
Abiri B, Vafa M. Vitamin C and cancer: the role of vitamin C in disease progression and quality of life in cancer patients. Nutr Cancer. 2021. 10.1080/01635581.2020.1795692.32691657 10.1080/01635581.2020.1795692
204. Samuel S Sitrin MD Vitamin D’s role in cell proliferation and differentiation Proc Nutr Rev 2008 66 S116 S124 10.1111/j.1753-4887.2008.00094.x
Samuel S, Sitrin MD. Vitamin D’s role in cell proliferation and differentiation. Proc Nutr Rev. 2008;66:S116–24.10.1111/j.1753-4887.2008.00094.x
205. Chandler PD Chen WY Ajala ON Hazra A Cook N Bubes V Lee IM Giovannucci EL Willett W Buring JE Effect of vitamin d3supplements on development of advanced cancer: a secondary analysis of the vital randomized clinical trial JAMA Netw Open 2020 10.1001/jamanetworkopen.2020.25850 33206192
Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, Lee IM, Giovannucci EL, Willett W, Buring JE, et al. Effect of vitamin d3supplements on development of advanced cancer: a secondary analysis of the vital randomized clinical trial. JAMA Netw Open. 2020. 10.1001/jamanetworkopen.2020.25850.33206192 10.1001/jamanetworkopen.2020.25850
206. Seraphin G Rieger S Hewison M Capobianco E Lisse TS The impact of vitamin D on cancer: a mini review J Steroid Biochem Mol Biol 2023 231 106308 10.1016/j.jsbmb.2023.106308 37054849
Seraphin G, Rieger S, Hewison M, Capobianco E, Lisse TS. The impact of vitamin D on cancer: a mini review. J Steroid Biochem Mol Biol. 2023;231:106308.37054849 10.1016/j.jsbmb.2023.106308
207. Jacobs ET Kohler LN Kunihiro AG Jurutka PW Vitamin D and colorectal, breast, and prostate cancers: a review of the epidemiological evidence J Cancer 2016 7 232 10.7150/jca.13403 26918035
Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW. Vitamin D and colorectal, breast, and prostate cancers: a review of the epidemiological evidence. J Cancer. 2016;7:232.26918035 10.7150/jca.13403
208. El-Sharkawy A Malki A Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications Molecules 2020 25 3219 10.3390/molecules25143219 32679655
El-Sharkawy A, Malki A. Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications. Molecules. 2020;25:3219.32679655 10.3390/molecules25143219
209. Abraham A Kattoor AJ Saldeen T Mehta JL Vitamin E and its anticancer effects Crit Rev Food Sci Nutr 2019 59 2831 2838 10.1080/10408398.2018.1474169 29746786
Abraham A, Kattoor AJ, Saldeen T, Mehta JL. Vitamin E and its anticancer effects. Crit Rev Food Sci Nutr. 2019;59:2831–8.29746786 10.1080/10408398.2018.1474169
210. Loh WQ Youn J Seow WJ Vitamin E intake and risk of prostate cancer: a meta-analysis Nutrients 2023 10.3390/nu15010014 38004138
Loh WQ, Youn J, Seow WJ. Vitamin E intake and risk of prostate cancer: a meta-analysis. Nutrients. 2023. 10.3390/nu15010014.38004138 10.3390/nu15010014
211. de Oliveira VA Oliveira IKF Pereira IC Mendes LKF da Silva FCC Torres-Leal FL de Azevedo Paiva A Consumption and supplementation of vitamin E in breast cancer risk, treatment, and outcomes: a systematic review with meta-analysis Clin Nutr ESPEN 2023 10.1016/j.clnesp.2023.01.032 38057036
de Oliveira VA, Oliveira IKF, Pereira IC, Mendes LKF, da Silva FCC, Torres-Leal FL, de Azevedo Paiva A. Consumption and supplementation of vitamin E in breast cancer risk, treatment, and outcomes: a systematic review with meta-analysis. Clin Nutr ESPEN. 2023. 10.1016/j.clnesp.2023.01.032.38057036 10.1016/j.clnesp.2023.01.032
212. Xie S Tan M Li H Li L Zhang H Wang Q Li S Yang J Xie H Chen P Study on the correlation between B vitamins and breast cancer Cancer Cell Int 2023 10.1186/s12935-023-02860-7 38110984
Xie S, Tan M, Li H, Li L, Zhang H, Wang Q, Li S, Yang J, Xie H, Chen P, et al. Study on the correlation between B vitamins and breast cancer. Cancer Cell Int. 2023. 10.1186/s12935-023-02860-7.38110984 10.1186/s12935-023-02860-7
213. Peterson CT Rodionov DA Peterson SN Osterman AL B vitamins and their role in immune regulation and cancer Nutrients 2020 12 3380 10.3390/nu12113380 33158037
Peterson CT, Rodionov DA, Peterson SN, Osterman AL. B vitamins and their role in immune regulation and cancer. Nutrients. 2020;12:3380.33158037 10.3390/nu12113380
214. Thabet RH Alessa REM Al-Smadi ZKK Alshatnawi BSG Amayreh BMI Al-Dwaaghreh RBA Salah SKA Folic acid: friend or foe in cancer therapy J Int Med Res 2024 10.1177/03000605231223064/ASSET/IMAGES/LARGE/10.1177_03000605231223064-FIG2.JPEG 38229460
Thabet RH, Alessa REM, Al-Smadi ZKK, Alshatnawi BSG, Amayreh BMI, Al-Dwaaghreh RBA, Salah SKA. Folic acid: friend or foe in cancer therapy. J Int Med Res. 2024. 10.1177/03000605231223064/ASSET/IMAGES/LARGE/10.1177_03000605231223064-FIG2.JPEG.38229460 10.1177/03000605231223064/ASSET/IMAGES/LARGE/10.1177_03000605231223064-FIG2.JPEG
215. Apostolou A Stagos D Galitsiou E Spyrou A Haroutounian S Portesis N Trizoglou I Wallace Hayes A Tsatsakis AM Kouretas D Assessment of polyphenolic content, antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of vitis vinifera stem extracts Food Chem Toxicol 2013 10.1016/j.fct.2013.01.029 23380202
Apostolou A, Stagos D, Galitsiou E, Spyrou A, Haroutounian S, Portesis N, Trizoglou I, Wallace Hayes A, Tsatsakis AM, Kouretas D. Assessment of polyphenolic content, antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of vitis vinifera stem extracts. Food Chem Toxicol. 2013. 10.1016/j.fct.2013.01.029.23380202 10.1016/j.fct.2013.01.029
216. Yoshioka Y Ohishi T Nakamura Y Fukutomi R Miyoshi N Anti-cancer effects of dietary polyphenols via ROS-mediated pathway with their modulation of MicroRNAs Molecules 2022 27 3816 10.3390/molecules27123816 35744941
Yoshioka Y, Ohishi T, Nakamura Y, Fukutomi R, Miyoshi N. Anti-cancer effects of dietary polyphenols via ROS-mediated pathway with their modulation of MicroRNAs. Molecules. 2022;27:3816.35744941 10.3390/molecules27123816
217. Rajagopal C Lankadasari MB Aranjani JM Harikumar KB Targeting oncogenic transcription factors by polyphenols: a novel approach for cancer therapy Pharmacol Res 2018 130 273 291 10.1016/j.phrs.2017.12.034 29305909
Rajagopal C, Lankadasari MB, Aranjani JM, Harikumar KB. Targeting oncogenic transcription factors by polyphenols: a novel approach for cancer therapy. Pharmacol Res. 2018;130:273–91.29305909 10.1016/j.phrs.2017.12.034
218. Fernandes R Costa C Fernandes R Barros AN Inflammation in prostate cancer: exploring the promising role of phenolic compounds as an innovative therapeutic approach Biomedicines 2023 11 3140 10.3390/biomedicines11123140 38137361
Fernandes R, Costa C, Fernandes R, Barros AN. Inflammation in prostate cancer: exploring the promising role of phenolic compounds as an innovative therapeutic approach. Biomedicines. 2023;11:3140.38137361 10.3390/biomedicines11123140
219. Kang NJ Shin SH Lee HJ Lee KW Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis Pharmacol Ther 2011 130 310 324 10.1016/j.pharmthera.2011.02.004 21356239
Kang NJ, Shin SH, Lee HJ, Lee KW. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther. 2011;130:310–24.21356239 10.1016/j.pharmthera.2011.02.004
220. Kronski E Fiori ME Barbieri O Astigiano S Mirisola V Killian PH Bruno A Pagani A Rovera F Pfeffer U MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 Mol Oncol 2014 10.1016/j.molonc.2014.01.005 24484937
Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, et al. MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol. 2014. 10.1016/j.molonc.2014.01.005.24484937 10.1016/j.molonc.2014.01.005
221. Singh N Zaidi D Shyam H Sharma R Balapure AK Polyphenols sensitization potentiates susceptibility of Mcf-7 and Mda Mb-231 cells to centchroman PLoS ONE 2012 10.1371/journal.pone.0037736 23300670
Singh N, Zaidi D, Shyam H, Sharma R, Balapure AK. Polyphenols sensitization potentiates susceptibility of Mcf-7 and Mda Mb-231 cells to centchroman. PLoS ONE. 2012. 10.1371/journal.pone.0037736.23300670 10.1371/journal.pone.0037736
222. Cipolletti M Fernandez VS Montalesi E Marino M Fiocchetti M Beyond the antioxidant activity of dietary polyphenols in cancer: the modulation of estrogen receptors (ERs) signaling Int J Mol Sci 2018 19 2624 10.3390/ijms19092624 30189583
Cipolletti M, Fernandez VS, Montalesi E, Marino M, Fiocchetti M. Beyond the antioxidant activity of dietary polyphenols in cancer: the modulation of estrogen receptors (ERs) signaling. Int J Mol Sci. 2018;19:2624.30189583 10.3390/ijms19092624
223. Kopustinskiene DM Jakstas V Savickas A Bernatoniene J Flavonoids as anticancer agents Nutrients 2020 12 457 10.3390/nu12020457 32059369
Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12:457.32059369 10.3390/nu12020457
224. Chang M Zhu D Chen Y Zhang W Liu X Li XL Cheng Z Su Z Zhang J Lu Y Total flavonoids of litchi seed attenuate prostate cancer progression via inhibiting AKT/MTOR and NF-KB signaling pathways Front Pharmacol 2021 10.3389/fphar.2021.758219 35126101
Chang M, Zhu D, Chen Y, Zhang W, Liu X, Li XL, Cheng Z, Su Z, Zhang J, Lu Y, et al. Total flavonoids of litchi seed attenuate prostate cancer progression via inhibiting AKT/MTOR and NF-KB signaling pathways. Front Pharmacol. 2021. 10.3389/fphar.2021.758219.35126101 10.3389/fphar.2021.758219
225. Zughaibi TA Suhail M Tarique M Tabrez S Targeting PI3K/Akt/MTOR pathway by different flavonoids: a cancer chemopreventive approach Int J Mol Sci 2021 22 12455 10.3390/ijms222212455 34830339
Zughaibi TA, Suhail M, Tarique M, Tabrez S. Targeting PI3K/Akt/MTOR pathway by different flavonoids: a cancer chemopreventive approach. Int J Mol Sci. 2021;22:12455.34830339 10.3390/ijms222212455
226. Fadus MC Lau C Bikhchandani J Lynch HT Curcumin: an age-old anti-inflammatory and anti-neoplastic agent J Tradit Complement Med 2017 7 339 346 10.1016/j.jtcme.2016.08.002 28725630
Fadus MC, Lau C, Bikhchandani J, Lynch HT. Curcumin: an age-old anti-inflammatory and anti-neoplastic agent. J Tradit Complement Med. 2017;7:339–46.28725630 10.1016/j.jtcme.2016.08.002
227. Peng Y Ao M Dong B Jiang Y Yu L Chen Z Hu C Xu R Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures Drug Des Devel Ther 2021 15 4503 4525 10.2147/DDDT.S327378 34754179
Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Devel Ther. 2021;15:4503–25.34754179 10.2147/DDDT.S327378
228. Hao J Dai X Gao J Li Y Hou Z Chang Z Wang Y Curcumin suppresses colorectal tumorigenesis via the Wnt/β-catenin signaling pathway by downregulating axin2 Oncol Lett 2021 10.3892/ol.2021.12447 34820015
Hao J, Dai X, Gao J, Li Y, Hou Z, Chang Z, Wang Y. Curcumin suppresses colorectal tumorigenesis via the Wnt/β-catenin signaling pathway by downregulating axin2. Oncol Lett. 2021. 10.3892/ol.2021.12447.34820015 10.3892/ol.2021.12447
229. Sathyabhama M Priya Dharshini LC Karthikeyan A Kalaiselvi S Min T The credible role of curcumin in oxidative stress-mediated mitochondrial dysfunction in mammals Biomolecules 2022 12 1405 10.3390/biom12101405 36291614
Sathyabhama M, Priya Dharshini LC, Karthikeyan A, Kalaiselvi S, Min T. The credible role of curcumin in oxidative stress-mediated mitochondrial dysfunction in mammals. Biomolecules. 2022;12:1405.36291614 10.3390/biom12101405
230. Gupta N Verma K Nalla S Kulshreshtha A Lall R Prasad S Free radicals as a double-edged sword: the cancer preventive and therapeutic roles of curcumin Molecules 2020 25 5390 10.3390/molecules25225390 33217990
Gupta N, Verma K, Nalla S, Kulshreshtha A, Lall R, Prasad S. Free radicals as a double-edged sword: the cancer preventive and therapeutic roles of curcumin. Molecules. 2020;25:5390.33217990 10.3390/molecules25225390
231. Farnood PR Pazhooh RD Asemi Z Yousefi B Targeting signaling pathway by curcumin in osteosarcoma Curr Mol Pharmacol 2022 10.2174/1874467215666220408104341
Farnood PR, Pazhooh RD, Asemi Z, Yousefi B. Targeting signaling pathway by curcumin in osteosarcoma. Curr Mol Pharmacol. 2022. 10.2174/1874467215666220408104341.10.2174/1874467215666220408104341
232. Tewari D Bawari S Sharma S DeLiberto LK Bishayee A Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: a novel strategy for cancer prevention and therapy Pharmacol Ther 2021 227 107876 10.1016/j.pharmthera.2021.107876 33930452
Tewari D, Bawari S, Sharma S, DeLiberto LK, Bishayee A. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: a novel strategy for cancer prevention and therapy. Pharmacol Ther. 2021;227:107876.33930452 10.1016/j.pharmthera.2021.107876
233. Basak S Srinivas V Mallepogu A Duttaroy AK Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human placental trophoblasts Cell Biol Int 2020 10.1002/cbin.11324 32073198
Basak S, Srinivas V, Mallepogu A, Duttaroy AK. Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human placental trophoblasts. Cell Biol Int. 2020. 10.1002/cbin.11324.32073198 10.1002/cbin.11324
234. Cianfruglia L Minnelli C Laudadio E Scirè A Armeni T Side effects of curcumin: epigenetic and antiproliferative implications for normal dermal fibroblast and breast cancer cells Antioxidants 2019 10.3390/antiox8090382 31505772
Cianfruglia L, Minnelli C, Laudadio E, Scirè A, Armeni T. Side effects of curcumin: epigenetic and antiproliferative implications for normal dermal fibroblast and breast cancer cells. Antioxidants. 2019. 10.3390/antiox8090382.31505772 10.3390/antiox8090382
235. Li Z Le W Cui Z A novel therapeutic anticancer property of raw garlic extract via injection but not ingestion Cell Death Discov. 2018 10.1038/s41420-018-0122-x 30479841
Li Z, Le W, Cui Z. A novel therapeutic anticancer property of raw garlic extract via injection but not ingestion. Cell Death Discov. 2018. 10.1038/s41420-018-0122-x.30479841 10.1038/s41420-018-0122-x
236. Pandey P Khan F Alshammari N Saeed A Aqil F Saeed M Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: plant therapeutics in cancer management Front Pharmacol 2023 14 1154034 10.3389/fphar.2023.1154034 37021043
Pandey P, Khan F, Alshammari N, Saeed A, Aqil F, Saeed M. Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: plant therapeutics in cancer management. Front Pharmacol. 2023;14:1154034.37021043 10.3389/fphar.2023.1154034
237. Altonsy MO Habib TN Andrews SC Diallyl disulfide-induced apoptosis in a breast-cancer cell line (MCF-7) may be caused by inhibition of histone deacetylation Nutr Cancer 2012 10.1080/01635581.2012.721156 23163853
Altonsy MO, Habib TN, Andrews SC. Diallyl disulfide-induced apoptosis in a breast-cancer cell line (MCF-7) may be caused by inhibition of histone deacetylation. Nutr Cancer. 2012. 10.1080/01635581.2012.721156.23163853 10.1080/01635581.2012.721156
238. Lee EN Choi YW Kim HK Park JK Kim HJ Kim MJ Lee HW Kim KH Bae SS Kim BS Chloroform extract of aged black garlic attenuates TNF-α-induced ROS generation, VCAM-1 expression, NF-ΚB activation and adhesiveness for monocytes in human umbilical vein endothelial cells Phyther Res 2011 10.1002/ptr.3230
Lee EN, Choi YW, Kim HK, Park JK, Kim HJ, Kim MJ, Lee HW, Kim KH, Bae SS, Kim BS, et al. Chloroform extract of aged black garlic attenuates TNF-α-induced ROS generation, VCAM-1 expression, NF-ΚB activation and adhesiveness for monocytes in human umbilical vein endothelial cells. Phyther Res. 2011. 10.1002/ptr.3230.10.1002/ptr.3230
239. Kong F Lee BH Wei K 5-Hydroxymethylfurfural mitigates lipopolysaccharide-stimulated inflammation via suppression of MAPK, NF-ΚB and MTOR activation in RAW 264.7 Cells Molecules 2019 10.3390/molecules24020275 31847089
Kong F, Lee BH, Wei K. 5-Hydroxymethylfurfural mitigates lipopolysaccharide-stimulated inflammation via suppression of MAPK, NF-ΚB and MTOR activation in RAW 264.7 Cells. Molecules. 2019. 10.3390/molecules24020275.31847089 10.3390/molecules24020275
240. Arreola R Quintero-Fabián S López-Roa R Flores-Gutiérrez E Reyes-Grajeda J Carrera-Quintanar L Ortuño-Sahagún D Immunomodulation and anti-inflammatory effects of garlic compounds: discovery service for endeavour college of natural health library J Immunol Res 2015 2015 401630 10.1155/2015/401630 25961060
Arreola R, Quintero-Fabián S, López-Roa R, Flores-Gutiérrez E, Reyes-Grajeda J, Carrera-Quintanar L, Ortuño-Sahagún D. Immunomodulation and anti-inflammatory effects of garlic compounds: discovery service for endeavour college of natural health library. J Immunol Res. 2015;2015:401630.25961060 10.1155/2015/401630
241. Schäfer G Kaschula C The immunomodulation and anti-inflammatory effects of garlic organosulfur compounds in cancer chemoprevention Anticancer Agents Med Chem 2014 10.2174/18715206113136660370 24237225
Schäfer G, Kaschula C. The immunomodulation and anti-inflammatory effects of garlic organosulfur compounds in cancer chemoprevention. Anticancer Agents Med Chem. 2014. 10.2174/18715206113136660370.24237225 10.2174/18715206113136660370
242. Jasamai M Hui CS Azmi N Kumolosasi E Effect of Allium Sativum (Garlic) methanol extract on viability and apoptosis of human leukemic cell lines Trop J Pharm Res 2016 10.4314/tjpr.v15i7.18
Jasamai M, Hui CS, Azmi N, Kumolosasi E. Effect of Allium Sativum (Garlic) methanol extract on viability and apoptosis of human leukemic cell lines. Trop J Pharm Res. 2016. 10.4314/tjpr.v15i7.18.10.4314/tjpr.v15i7.18
243. Farzanegi P Abbaszadeh H Farokhi F Rahmati-Ahmadabad S Hosseini SA Ahmad A Mazandarani MR Rezaei I Shokrie M Vizvari E Attenuated renal and hepatic cells apoptosis following swimming exercise supplemented with garlic extract in old rats Clin Interv Aging 2020 10.2147/CIA.S250321 32884250
Farzanegi P, Abbaszadeh H, Farokhi F, Rahmati-Ahmadabad S, Hosseini SA, Ahmad A, Mazandarani MR, Rezaei I, Shokrie M, Vizvari E, et al. Attenuated renal and hepatic cells apoptosis following swimming exercise supplemented with garlic extract in old rats. Clin Interv Aging. 2020. 10.2147/CIA.S250321.32884250 10.2147/CIA.S250321
244. Özkan İ Koçak P Yıldırım M Ünsal N Yılmaz H Telci D Şahin F Garlic (Allium Sativum)-derived SEVs inhibit cancer cell proliferation and induce caspase mediated apoptosis Sci Rep 2021 10.1038/s41598-021-93876-4 34285262
Özkan İ, Koçak P, Yıldırım M, Ünsal N, Yılmaz H, Telci D, Şahin F. Garlic (Allium Sativum)-derived SEVs inhibit cancer cell proliferation and induce caspase mediated apoptosis. Sci Rep. 2021. 10.1038/s41598-021-93876-4.34285262 10.1038/s41598-021-93876-4
245. Upadhyay RK Garlic induced apoptosis, cell cycle check points and inhibition of cancer cell proliferation J Cancer Res Treat 2017 5 35 54
Upadhyay RK. Garlic induced apoptosis, cell cycle check points and inhibition of cancer cell proliferation. J Cancer Res Treat. 2017;5:35–54.
246. Zhu Z Liao L Gao M Liu Q Garlic-derived exosome-like nanovesicles alleviate dextran sulphate sodium-induced mouse colitis via the TLR4/MyD88/NF-ΚB pathway and gut microbiota modulation Food Funct 2023 10.1039/d3fo01094e 37982812
Zhu Z, Liao L, Gao M, Liu Q. Garlic-derived exosome-like nanovesicles alleviate dextran sulphate sodium-induced mouse colitis via the TLR4/MyD88/NF-ΚB pathway and gut microbiota modulation. Food Funct. 2023. 10.1039/d3fo01094e.37982812 10.1039/d3fo01094e
247. Chang Z An L He Z Zhang Y Li S Lei M Xu P Lai Y Jiang Z Huang Y Allicin suppressed escherichia coli-induced urinary tract infections by a novel MALT1/NF-ΚB pathway Food Funct 2022 10.1039/d1fo03853b 36449017
Chang Z, An L, He Z, Zhang Y, Li S, Lei M, Xu P, Lai Y, Jiang Z, Huang Y, et al. Allicin suppressed escherichia coli-induced urinary tract infections by a novel MALT1/NF-ΚB pathway. Food Funct. 2022. 10.1039/d1fo03853b.36449017 10.1039/d1fo03853b
248. Shao X Li J Zhang H Zhang X Sun C Ouyang X Wang Y Wu X Chen C Anti-inflammatory effects and molecular mechanisms of bioactive small molecule garlic polysaccharide Front Nutr 2023 10.3389/fnut.2022.1092873 37771754
Shao X, Li J, Zhang H, Zhang X, Sun C, Ouyang X, Wang Y, Wu X, Chen C. Anti-inflammatory effects and molecular mechanisms of bioactive small molecule garlic polysaccharide. Front Nutr. 2023. 10.3389/fnut.2022.1092873.37771754 10.3389/fnut.2022.1092873
249. Saud SM Li W Gray Z Matter MS Colburn NH Young MR Kim YS Diallyl disulfide (DADS), a constituent of garlic, inactivates NF-ΚB and prevents colitis-induced colorectal cancer by inhibiting GSK-3β Cancer Prev Res 2016 10.1158/1940-6207.CAPR-16-0044
Saud SM, Li W, Gray Z, Matter MS, Colburn NH, Young MR, Kim YS. Diallyl disulfide (DADS), a constituent of garlic, inactivates NF-ΚB and prevents colitis-induced colorectal cancer by inhibiting GSK-3β. Cancer Prev Res. 2016. 10.1158/1940-6207.CAPR-16-0044.10.1158/1940-6207.CAPR-16-0044
250. Sen S Chakraborty R The role of antioxidants in human health ACS Symp Ser 2011 10.1021/bk-2011-1083.ch001
Sen S, Chakraborty R. The role of antioxidants in human health. ACS Symp Ser. 2011. 10.1021/bk-2011-1083.ch001.10.1021/bk-2011-1083.ch001
251. Gao S Hu M Bioavailability challenges associated with development of anti-cancer phenolics Mini-Rev Med Chem 2010 10.2174/138955710791384081 20408802
Gao S, Hu M. Bioavailability challenges associated with development of anti-cancer phenolics. Mini-Rev Med Chem. 2010. 10.2174/138955710791384081.20408802 10.2174/138955710791384081
252. Żyżelewicz D Oracz J Bioavailability and bioactivity of plant antioxidants Antioxidants 2022 11 2336 10.3390/antiox11122336 36552544
Żyżelewicz D, Oracz J. Bioavailability and bioactivity of plant antioxidants. Antioxidants. 2022;11:2336.36552544 10.3390/antiox11122336
253. Meulmeester FL Luo J Martens LG Mills K van Heemst D Noordam R Antioxidant supplementation in oxidative stress-related diseases: What have we learned from studies on alpha-tocopherol? Antioxidants 2022 11 2322 10.3390/antiox11122322 36552530
Meulmeester FL, Luo J, Martens LG, Mills K, van Heemst D, Noordam R. Antioxidant supplementation in oxidative stress-related diseases: What have we learned from studies on alpha-tocopherol? Antioxidants. 2022;11:2322.36552530 10.3390/antiox11122322
254. Jomova K Raptova R Alomar SY Alwasel SH Nepovimova E Kuca K Valko M Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging Arch Toxicol 2023 97 2499 2574 10.1007/s00204-023-03562-9 37597078
Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97:2499–574.37597078 10.1007/s00204-023-03562-9
255. Schmidt HHHW Stocker R Vollbracht C Paulsen G Riley D Daiber A Cuadrado A Antioxidants in translational medicine Antioxidants Redox Signal 2015 10.1089/ars.2015.6393
Schmidt HHHW, Stocker R, Vollbracht C, Paulsen G, Riley D, Daiber A, Cuadrado A. Antioxidants in translational medicine. Antioxidants Redox Signal. 2015. 10.1089/ars.2015.6393.10.1089/ars.2015.6393
256. Paller CJ Denmeade SR Carducci MA Challenges of conducting clinical trials of natural products to combat cancer Clin Adv Hematol Oncol 2016 14 447 455 27379814
Paller CJ, Denmeade SR, Carducci MA. Challenges of conducting clinical trials of natural products to combat cancer. Clin Adv Hematol Oncol. 2016;14:447–55.27379814
257. WHO Expert Committee on Specifications for Pharmaceutical Preparations Good Regulatory Practices in the Regulation of Medical Products. WHO - Tech. Rep. Ser. 1033 2021, 269–304.
258. Zhang H Zhou L Davies KJA Forman HJ Silencing Bach1 alters aging-related changes in the expression of Nrf2-regulated genes in primary human bronchial epithelial cells Arch Biochem Biophys 2019 672 108074 10.1016/j.abb.2019.108074 31422075
Zhang H, Zhou L, Davies KJA, Forman HJ. Silencing Bach1 alters aging-related changes in the expression of Nrf2-regulated genes in primary human bronchial epithelial cells. Arch Biochem Biophys. 2019;672:108074.31422075 10.1016/j.abb.2019.108074
259. Surh YJ Kundu JK Na HK Lee JS Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals J Nutr 2005 135 2993S 3001S 10.1093/jn/135.12.2993S 16317160
Surh YJ, Kundu JK, Na HK, Lee JS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr. 2005;135:2993S-3001S.16317160 10.1093/jn/135.12.2993S
260. Bansal A Celeste Simon M Glutathione metabolism in cancer progression and treatment resistance J Cell Biol 2018 217 2291 10.1083/jcb.201804161 29915025
Bansal A, Celeste Simon M. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217:2291.29915025 10.1083/jcb.201804161
261. Wiel C Le Gal K Ibrahim MX Jahangir CA Kashif M Yao H Ziegler DV Xu X Ghosh T Mondal T BACH1 stabilization by antioxidants stimulates lung cancer metastasis Cell 2019 10.1016/j.cell.2019.06.005 31257027
Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, Ziegler DV, Xu X, Ghosh T, Mondal T, et al. BACH1 stabilization by antioxidants stimulates lung cancer metastasis. Cell. 2019. 10.1016/j.cell.2019.06.005.31257027 10.1016/j.cell.2019.06.005
262. Sayin VI Ibrahim MX Larsson E Nilsson JA Lindahl P Bergo MO Cancer: antioxidants accelerate lung cancer progression in mice Sci Transl Med 2014 10.1126/scitranslmed.3007653 24477002
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Cancer: antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014. 10.1126/scitranslmed.3007653.24477002 10.1126/scitranslmed.3007653
263. Calderaro A Patanè GT Tellone E Barreca D Ficarra S Misiti F Laganà G The neuroprotective potentiality of flavonoids on Alzheimer’s disease Int J Mol Sci 2022 23 14835 10.3390/ijms232314835 36499159
Calderaro A, Patanè GT, Tellone E, Barreca D, Ficarra S, Misiti F, Laganà G. The neuroprotective potentiality of flavonoids on Alzheimer’s disease. Int J Mol Sci. 2022;23:14835.36499159 10.3390/ijms232314835
264. Sano M Ernesto C Thomas RG Klauber MR Schafer K Grundman M Woodbury P Growdon J Cotman CW Pfeiffer E A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease N Engl J Med 1997 10.1056/nejm199704243361704 9110909
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med. 1997. 10.1056/nejm199704243361704.9110909 10.1056/nejm199704243361704
265. Bin Q Hu X Cao Y Gao F The role of vitamin E (Tocopherol) supplementation in the prevention of stroke: a meta-analysis of 13 randomised controlled trials Thromb Haemost 2011 10.1160/TH10-11-0729 22116307
Bin Q, Hu X, Cao Y, Gao F. The role of vitamin E (Tocopherol) supplementation in the prevention of stroke: a meta-analysis of 13 randomised controlled trials. Thromb Haemost. 2011. 10.1160/TH10-11-0729.22116307 10.1160/TH10-11-0729
266. Polidori M Nelles G Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease – challenges and perspectives Curr Pharm Des 2014 10.2174/13816128113196660706 24079767
Polidori M, Nelles G. Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease – challenges and perspectives. Curr Pharm Des. 2014. 10.2174/13816128113196660706.24079767 10.2174/13816128113196660706
267. Elmund B Hartrianti P Evaluation of mangosteen (Garcinia Mangostana) antioxidant activity in clinical trials and in vivo animal studies: a systematic review J Appl Pharm Sci 2020 10.7324/JAPS.2020.101216
Elmund B, Hartrianti P. Evaluation of mangosteen (Garcinia Mangostana) antioxidant activity in clinical trials and in vivo animal studies: a systematic review. J Appl Pharm Sci. 2020. 10.7324/JAPS.2020.101216.10.7324/JAPS.2020.101216
268. Marmitt DJ Bitencourt S da Silva GR Rempel C Goettert MI Traditional plants with antioxidant properties in clinical trials—a systematic review Phyther Res 2021 35 5647 5667 10.1002/ptr.7202
Marmitt DJ, Bitencourt S, da Silva GR, Rempel C, Goettert MI. Traditional plants with antioxidant properties in clinical trials—a systematic review. Phyther Res. 2021;35:5647–67.10.1002/ptr.7202
269. Raijmakers MTM Dechend R Poston L Oxidative stress and preeclampsia: rationale for antioxidant clinical trials Hypertension 2004 44 374 380 10.1161/01.HYP.0000141085.98320.01 15326082
Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44:374–80.15326082 10.1161/01.HYP.0000141085.98320.01
270. Mecocci P Polidori MC Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease Biochim Biophys Acta - Mol Basis Dis 2012 1822 631 638 10.1016/j.bbadis.2011.10.006
Mecocci P, Polidori MC. Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease. Biochim Biophys Acta - Mol Basis Dis. 2012;1822:631–8.10.1016/j.bbadis.2011.10.006
271. Sies H Berndt C Jones DP Oxidative stress Annu Rev Biochem 2017 10.1146/annurev-biochem-061516-045037 28441057
Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017. 10.1146/annurev-biochem-061516-045037.28441057 10.1146/annurev-biochem-061516-045037
272. Ren H Yu H Zhang S Liang S Zheng X Zhang S Yao P Zheng H Qi X Genome sequencing provides insights into the evolution and antioxidant activity of Chinese bayberry BMC Genom 2019 10.1186/s12864-019-5818-7
Ren H, Yu H, Zhang S, Liang S, Zheng X, Zhang S, Yao P, Zheng H, Qi X. Genome sequencing provides insights into the evolution and antioxidant activity of Chinese bayberry. BMC Genom. 2019. 10.1186/s12864-019-5818-7.10.1186/s12864-019-5818-7
273. Yu L Diao S Zhang G Yu J Zhang T Luo H Duan A Wang J He C Zhang J Genome sequence and population genomics provide insights into chromosomal evolution and phytochemical innovation of hippophae rhamnoides Plant Biotechnol J 2022 10.1111/pbi.13802 36478140
Yu L, Diao S, Zhang G, Yu J, Zhang T, Luo H, Duan A, Wang J, He C, Zhang J. Genome sequence and population genomics provide insights into chromosomal evolution and phytochemical innovation of hippophae rhamnoides. Plant Biotechnol J. 2022. 10.1111/pbi.13802.36478140 10.1111/pbi.13802
274. Agyeman AS Chaerkady R Shaw PG Davidson NE Visvanathan K Pandey A Kensler TW Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles Breast Cancer Res Treat 2012 10.1007/s10549-011-1536-9 21597922
Agyeman AS, Chaerkady R, Shaw PG, Davidson NE, Visvanathan K, Pandey A, Kensler TW. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res Treat. 2012. 10.1007/s10549-011-1536-9.21597922 10.1007/s10549-011-1536-9
275. Gupta R Srivastava D Sahu M Tiwari S Ambasta RK Kumar P Artificial intelligence to deep learning: machine intelligence approach for drug discovery Mol Divers 2021 10.1007/s11030-021-10217-3 34554395
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021. 10.1007/s11030-021-10217-3.34554395 10.1007/s11030-021-10217-3
276. Kumari Patial P Sud D Bioactive phytosteroids from Araucaria Columnaris (G. Forst.) Hook: RP-HPLC-DAD analysis, in-vitro antioxidant potential, in-silico computational study and molecular docking against 3MNG and 1N3U Steroids 2022 10.1016/j.steroids.2022.109116 36174751
Kumari Patial P, Sud D. Bioactive phytosteroids from Araucaria Columnaris (G. Forst.) Hook: RP-HPLC-DAD analysis, in-vitro antioxidant potential, in-silico computational study and molecular docking against 3MNG and 1N3U. Steroids. 2022. 10.1016/j.steroids.2022.109116.36174751 10.1016/j.steroids.2022.109116
277. Zu G Sun K Li L Zu X Han T Huang H Mechanism of quercetin therapeutic targets for Alzheimer disease and Type 2 diabetes mellitus Sci Rep 2021 10.1038/s41598-021-02248-5 34824300
Zu G, Sun K, Li L, Zu X, Han T, Huang H. Mechanism of quercetin therapeutic targets for Alzheimer disease and Type 2 diabetes mellitus. Sci Rep. 2021. 10.1038/s41598-021-02248-5.34824300 10.1038/s41598-021-02248-5
278. Idowu SO Fatokun AA Artificial intelligence (AI) to the rescue: deploying machine learning to bridge the biorelevance gap in antioxidant assays SLAS Technol 2021 26 16 25 10.1177/2472630320962716 33054529
Idowu SO, Fatokun AA. Artificial intelligence (AI) to the rescue: deploying machine learning to bridge the biorelevance gap in antioxidant assays. SLAS Technol. 2021;26:16–25.33054529 10.1177/2472630320962716
279. Wang H Fu T Du Y Gao W Huang K Liu Z Chandak P Liu S Van Katwyk P Deac A Scientific discovery in the age of artificial intelligence Nature 2023 620 47 60 10.1038/s41586-023-06221-2 37532811
Wang H, Fu T, Du Y, Gao W, Huang K, Liu Z, Chandak P, Liu S, Van Katwyk P, Deac A, et al. Scientific discovery in the age of artificial intelligence. Nature. 2023;620:47–60.37532811 10.1038/s41586-023-06221-2
280. Janairo JIB Machine learning for the cleaner production of antioxidant peptides Int J Pept Res Ther 2021 10.1007/s10989-021-10232-w
Janairo JIB. Machine learning for the cleaner production of antioxidant peptides. Int J Pept Res Ther. 2021. 10.1007/s10989-021-10232-w.10.1007/s10989-021-10232-w
281. Alam S Khan F 3D-QSAR, docking, ADME/Tox studies on flavone analogs reveal anticancer activity through tankyrase inhibition Sci Rep 2019 10.1038/s41598-019-41984-7 31882854
Alam S, Khan F. 3D-QSAR, docking, ADME/Tox studies on flavone analogs reveal anticancer activity through tankyrase inhibition. Sci Rep. 2019. 10.1038/s41598-019-41984-7.31882854 10.1038/s41598-019-41984-7
282. Zhang Y Li Y Quan Z Xiao P Duan J-A New insights into antioxidant peptides: an overview of efficient screening, evaluation models, molecular mechanisms, and applications Antioxidants 2024 13 203 10.3390/antiox13020203 38397801
Zhang Y, Li Y, Quan Z, Xiao P, Duan J-A. New insights into antioxidant peptides: an overview of efficient screening, evaluation models, molecular mechanisms, and applications. Antioxidants. 2024;13:203.38397801 10.3390/antiox13020203
283. Tragni V Primiano G Tummolo A Beltrame L Lapiana G Sgobba M Cavalluzzi M Paterno G Gorgoglione R Volpicella M Personalized medicine in mitochondrial health and disease: molecular basis of therapeutic approaches based on nutritional supplements and their analogs Molecules 2022 27 11 3494 10.3390/molecules27113494 35684429
Tragni V, Primiano G, Tummolo A, Beltrame L, Lapiana G, Sgobba M, Cavalluzzi M, Paterno G, Gorgoglione R, Volpicella M, et al. Personalized medicine in mitochondrial health and disease: molecular basis of therapeutic approaches based on nutritional supplements and their analogs. Molecules. 2022;27(11):3494. 10.3390/molecules27113494.35684429 10.3390/molecules27113494
284. Yanpanitch OU Hatairaktham S Charoensakdi R Panichkul N Fucharoen S Srichairatanakool S Siritanaratkul N Kalpravidh RW Treatment of β -Thalassemia/Hemoglobin e with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state Oxid Med Cell Longev 2015 2015 1 537954 10.1155/2015/537954 26078808
Yanpanitch OU, Hatairaktham S, Charoensakdi R, Panichkul N, Fucharoen S, Srichairatanakool S, Siritanaratkul N, Kalpravidh RW. Treatment of β -Thalassemia/Hemoglobin e with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state. Oxid Med Cell Longev. 2015;2015(1): 537954. 10.1155/2015/537954.26078808 10.1155/2015/537954
285. Sergouniotis PI Fitzgerald T Birney E From genetic variation to precision medicine Cambridge Prism Precis Med 2023 1 e7 10.1017/pcm.2022.11 38550939
Sergouniotis PI, Fitzgerald T, Birney E. From genetic variation to precision medicine. Cambridge Prism Precis Med. 2023;1: e7. 10.1017/pcm.2022.11.38550939 10.1017/pcm.2022.11
286. Ulasov AV Rosenkranz AA Georgiev GP Sobolev AS Nrf2/Keap1/ARE signaling: towards specific regulation Life Sci 2022 291 120111 10.1016/j.lfs.2021.120111 34732330
Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS. Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci. 2022;291: 120111.34732330 10.1016/j.lfs.2021.120111
287. Wang H Wang B Wei J Zheng Z Su J Bian C Xin Y Jiang X Sulforaphane regulates Nrf2-mediated antioxidant activity and downregulates TGF-Β1/Smad pathways to prevent radiation-induced muscle fibrosis Life Sci 2022 311 121197 10.1016/j.lfs.2022.121197 36400201
Wang H, Wang B, Wei J, Zheng Z, Su J, Bian C, Xin Y, Jiang X. Sulforaphane regulates Nrf2-mediated antioxidant activity and downregulates TGF-Β1/Smad pathways to prevent radiation-induced muscle fibrosis. Life Sci. 2022;311: 121197. 10.1016/j.lfs.2022.121197.36400201 10.1016/j.lfs.2022.121197
288. Zhou DD Luo M Shang A Mao QQ Li BY Gan RY Li H Bin antioxidant food components for the prevention and treatment of cardiovascular diseases: effects, mechanisms, and clinical studies Oxid Med Cell Longev 2021 2021 1 6627355 10.1155/2021/6627355 33574978
Zhou DD, Luo M, Shang A, Mao QQ, Li BY, Gan RY, Li H. Bin antioxidant food components for the prevention and treatment of cardiovascular diseases: effects, mechanisms, and clinical studies. Oxid Med Cell Longev. 2021;2021(1):6627355.33574978 10.1155/2021/6627355
289. Jakubiak GK Osadnik K Lejawa M Osadnik T Goławski M Lewandowski P Pawlas N “Obesity and insulin resistance” is the component of the metabolic syndrome most strongly associated with oxidative stress Antioxidants 2022 11 1 79 10.3390/antiox11010079
Jakubiak GK, Osadnik K, Lejawa M, Osadnik T, Goławski M, Lewandowski P, Pawlas N. “Obesity and insulin resistance” is the component of the metabolic syndrome most strongly associated with oxidative stress. Antioxidants. 2022;11(1):79. 10.3390/antiox11010079.10.3390/antiox11010079
290. Ávila-Escalante ML Coop-Gamas F Cervantes-Rodríguez M Méndez-Iturbide D Aranda-González II The effect of diet on oxidative stress and metabolic diseases—clinically controlled trials J Food Biochem 2020 44 5 e13191 10.1111/jfbc.13191 32160647
Ávila-Escalante ML, Coop-Gamas F, Cervantes-Rodríguez M, Méndez-Iturbide D, Aranda-González II. The effect of diet on oxidative stress and metabolic diseases—clinically controlled trials. J Food Biochem. 2020;44(5): e13191.32160647 10.1111/jfbc.13191
291. Tun S Spainhower CJ Cottrill CL Lakhani HV Pillai SS Dilip A Chaudhry H Shapiro JI Sodhi K Therapeutic efficacy of antioxidants in ameliorating obesity phenotype and associated comorbidities Front Pharmacol 2020 11 1234 10.3389/fphar.2020.01234 32903449
Tun S, Spainhower CJ, Cottrill CL, Lakhani HV, Pillai SS, Dilip A, Chaudhry H, Shapiro JI, Sodhi K. Therapeutic efficacy of antioxidants in ameliorating obesity phenotype and associated comorbidities. Front Pharmacol. 2020;11:1234.32903449 10.3389/fphar.2020.01234
292. Moloney, J.N.; Cotter, T.G. ROS Signalling in the Biology of Cancer. In: Semin. Cell Dev. Biol. 2018, 80.
293. Hayes JD Dinkova-Kostova AT Tew KD Oxidative stress in cancer Cancer Cell 2020 38 2 167 197 10.1016/j.ccell.2020.06.001 32649885
Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167–97.32649885 10.1016/j.ccell.2020.06.001
294. George S Abrahamse H Redox potential of antioxidants in cancer progression and prevention Antioxidants 2020 9 1156 10.3390/antiox9111156 33233630
George S, Abrahamse H. Redox potential of antioxidants in cancer progression and prevention. Antioxidants. 2020;9:1156.33233630 10.3390/antiox9111156
295. Slika H Mansour H Wehbe N Nasser SA Iratni R Nasrallah G Shaito A Ghaddar T Kobeissy F Eid AH Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms Biomed Pharmacother 2022 146 112442 10.1016/j.biopha.2021.112442 35062053
Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, Shaito A, Ghaddar T, Kobeissy F, Eid AH. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442.35062053 10.1016/j.biopha.2021.112442
296. Michalak M Pierzak M Kręcisz B Suliga E Bioactive compounds for skin health: a review Nutrients 2021 13 203 10.3390/nu13010203 33445474
Michalak M, Pierzak M, Kręcisz B, Suliga E. Bioactive compounds for skin health: a review. Nutrients. 2021;13:203.33445474 10.3390/nu13010203
297. Azevedo Martins TE de Oliveira S Pinto CA Costa de Oliveira A Robles Velasco MV Gorriti Guitiérrez AR Cosquillo Rafael MF Retuerto-Figueroa MG Contribution of topical antioxidants to maintain healthy skin—a review Sci Pharm 2020 88 27 10.3390/scipharm88020027
Azevedo Martins TE, de Oliveira S, Pinto CA, Costa de Oliveira A, Robles Velasco MV, Gorriti Guitiérrez AR, Cosquillo Rafael MF, Retuerto-Figueroa MG. Contribution of topical antioxidants to maintain healthy skin—a review. Sci Pharm. 2020;88:27.10.3390/scipharm88020027
298. Tavassolifar MJ Vodjgani M Salehi Z Izad M The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis Autoimmune Dis 2020 2020 5793817 32789026
Tavassolifar MJ, Vodjgani M, Salehi Z, Izad M. The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis. Autoimmune Dis. 2020;2020:5793817.32789026
299. Zhao Y Dai C Wang Z Chen W Liu J Zhuo R Yu A Huang S A novel curcumin-loaded composite dressing facilitates wound healing due to its natural antioxidant effect Drug Des Devel Ther 2019 10.2147/DDDT.S219224 32099322
Zhao Y, Dai C, Wang Z, Chen W, Liu J, Zhuo R, Yu A, Huang S. A novel curcumin-loaded composite dressing facilitates wound healing due to its natural antioxidant effect. Drug Des Devel Ther. 2019. 10.2147/DDDT.S219224.32099322 10.2147/DDDT.S219224
300. Vaiserman A Koliada A Zayachkivska A Lushchak O Nanodelivery of natural antioxidants: an anti-aging perspective Front Bioeng Biotechnol 2020 7 447 10.3389/fbioe.2019.00447 31998711
Vaiserman A, Koliada A, Zayachkivska A, Lushchak O. Nanodelivery of natural antioxidants: an anti-aging perspective. Front Bioeng Biotechnol. 2020;7:447.31998711 10.3389/fbioe.2019.00447
301. Akbari B Baghaei-Yazdi N Bahmaie M Mahdavi Abhari F The role of plant-derived natural antioxidants in reduction of oxidative stress BioFactors 2022 48 611 633 10.1002/biof.1831 35229925
Akbari B, Baghaei-Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant-derived natural antioxidants in reduction of oxidative stress. BioFactors. 2022;48:611–33.35229925 10.1002/biof.1831
302. Jideani AIO Silungwe H Takalani T Omolola AO Udeh HO Anyasi TA Antioxidant-rich natural fruit and vegetable products and human health Int J Food Prop 2021 24 41 67 10.1080/10942912.2020.1866597
Jideani AIO, Silungwe H, Takalani T, Omolola AO, Udeh HO, Anyasi TA. Antioxidant-rich natural fruit and vegetable products and human health. Int J Food Prop. 2021;24:41–67.10.1080/10942912.2020.1866597
303. Shah AK Dhalla NS Effectiveness of some vitamins in the prevention of cardiovascular disease: a narrative review Front Physiol 2021 12 729255 10.3389/fphys.2021.729255 34690803
Shah AK, Dhalla NS. Effectiveness of some vitamins in the prevention of cardiovascular disease: a narrative review. Front Physiol. 2021;12:729255.34690803 10.3389/fphys.2021.729255
